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Abstract 
Simple carbohydrates constitute a big part of our everyday diet, as significant consumption increases 
have occurred in recent decades. This has coincided with a dramatic rise in people suffering from 
metabolic disorders, such as diabetes and obesity. However, the genetic factors ensuring a healthy 
response to sugar intake remain poorly understood. To keep blood glucose in a healthy range even 
upon overnight fasting or following a rich meal, animals need to be able to adapt quickly. In a healthy 
organism, high sugar intake leads to rapid conversion of excess sugars into stored glycogen and 
triacylglycerols, while starvation triggers glucose production through gluconeogenesis and glycogen 
breakdown. To cope with these fluctuating nutritional conditions organisms possess glucose-sensing 
mechanisms. Such pathways have a key role in monitoring changes in cellular and organismal nutrient 
status and readjusting animal physiology accordingly to maintain homeostasis.  
Intracellular sugar metabolites are sensed by the conserved Mondo family transcription factors 
(MondoA and MondoB/ChREBP in mammals, Mondo in Drosophila), which act together with 
transcription factor Mlx. Together, they control the expression of metabolic target genes by binding 
to the carbohydrate response elements (ChoREs) present in their promoters. The known Mondo-Mlx 
targets include genes involved in carbohydrate metabolism and biosynthesis of fatty acids and TAGs. 
Yet, the physiological output of these transcription factors has remained largely elusive. As these 
transcription factors are very well conserved in Drosophila, this model organism has been used in this 
thesis to understand the physiological role of Mondo-Mlx and their target genes in vivo. 
We demonstrate that Mondo-Mlx interact in the fly and are crucial for dietary sugar tolerance. Loss 
of either transcription factor leads to impaired growth and lethality upon high sugar diet. We further 
characterize the mlx mutant phenotype to reveal high circulating glucose, and increased glycogen 
levels. We uncover transcriptional repressor Cabut as a direct target of Mondo-Mlx. The Cabut 
promoter contains two conserved ChoREs that are directly bound by Mondo-Mlx in a sugar-
dependent manner. Loss of Cabut similarly results in dietary sugar intolerance, pointing to a crucial 
function in carbohydrate metabolism. We discover that Mondo-Mlx through Cabut are essential for 
repressing the expression of pepck – the rate limiting gene in gluconeogenesis and glyceroneogenesis. 
A failure to regulate this step results in pepck over-expression, leading to several fold higher levels of 
circulating glycerol, and pupal lethality of mlx mutants. Moreover, we reveal that Cabut interconnects 
nutrient sensing with the circadian clock, and contributes to circadian gene expression oscillation. 
Additionally to Cabut, we identify Salt inducible kinase 3 (SIK3) as a direct transcriptional target of 
Mondo-Mlx required for dietary sugar tolerance. Moreover, we show that the activity of the rate 
limiting enzyme in the pentose phosphate pathway, glucose-6-phosphate dehydrogenase (G6PD), is 
increased following sugar feeding. In addition to transcriptional upregulation by Mondo-Mlx, we 
demonstrate that sugar-augmented increase in G6PD activity is achieved through SIK3-dependent 
activating G6PD phosphorylation. Collectively, our results demonstrate that Mondo-Mlx-mediated 
transcriptional upregulation, as well as SIK3-dependent phosphorylation promote G6PD enzyme 
activity in response to high high sugar diets. The subsequent increase in G6PD activity is required for 
elevating NADPH/NADP+ ratio in order to reduce glutathione in high sugar conditions. We determine 
that upregulating G6PD activity through Mondo-Mlx and SIK3 is essential for redox balance 
maintenance and this mechanism contributes to dietary sugar tolerance. 
In sum, the results of this thesis demonstrate that maintaining redox balance, directing the flow of 
carbon backbones, and regulating the expression of metabolic circadian genes is essential for dietary 
sugar tolerance. We highlight the central role of Mondo-Mlx in orchestrating the necessary 
transcriptional response required for safe glucose utilization, and ultimately, for maintaining 
metabolic homeostasis.
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1. Overview of literature 
1.1 A brief history of human carbohydrate consumption 
For the majority of omnivorous and herbivorous animals, carbohydrates constitute a substantial part 
of energy intake. However, the diet of a pre-historic man, practicing mainly a hunter’s and a forager’s 
lifestyle, was rich in protein, moderately abundant in fats and fairly scarce in carbohydrates. Protein 
from game meat covered the bulk of daily energetic needs, supplemented with occasional 
carbohydrates in the form of consumed berries, roots, and leaves (Yudkin, 1967). It is hypothesized 
that the implementation of cooking has been one of the break-through events in utilizing 
carbohydrates. Namely, in its raw form dietary starches are ingested only slowly and partially, 
whereas cooking starchy foods, such as roots and tubers, greatly increases their speed of ingestion 
(Hardy et al., 2015) and thus opened up a whole plethora of potential energy sources. 
The low intake of carbohydrates and especially starches changed dramatically with the adoption of 
agriculture during the Neolithic revolution 11000 to 3500 years ago (Bellwood et al., 2007). As a 
striking contrast to the pre-historic man’s diet, the cultivation of cereals introduced starches as one of 
the main macronutrient groups.  
Up to the 18th and 19th century, our ancestors had limited access to simple sugars – a rare treat in the 
form of berries, fruits, and honey. However, by the 20th , simple sugar consumption had exponentially 
grown and the sweeteners had become a habitual part of our diets (reviewed in (Tappy and Lê, 2010). 
It is noteworthy, that during more recent decades, the consumption of simple sugars with diet, mainly 
in the form of fructose (Fru) has increased by 50% since the 1970s in the USA (Vos et al., 2008). 
According to the modern (2014) Finnish nutrition recommendations (Valtion 
ravitsemusneuvottelukunta, 2014) 45-60% daily energetic needs are recommended to be covered by 
carbohydrates, while less than 10% should be consumed in the form of simple sugars. Thus, the 
majority of carbohydrates currently recommended to be consumed is in the form of starches, such as 
grains and vegetables. 
1.2 The importance of glucose homeostasis 
While the quantity of dietary carbohydrates needed for human nutrition is disputed (Westman, 2002), 
it is noteworthy that certain tissues in the human body depend heavily on glucose (Glc) as a source of 
energy. These include the brain, erythrocytes, renal medulla, lens and cornea of the eye, and testes 
(Ferrier, 2013). For example, the brain has only a limited capacity to store glycogen in astrocytes and 
neurons (Dinuzzo et al., 2010). Moreover, other potential energy sources such as free fatty acids 
(FFAs) are impermeable to the blood-brain barrier, and alternatives, such as ketone bodies, are 
generally present in low levels (Gerich, 2000). Although, after prolonged fasting or carbohydrate 
withdrawal, ketone bodies will be produced to help cover the energetic needs of the human brain 
(Owen et al., 1967), the plasma Glc is the preferred source of energy for the central nervous system 
(CNS). Moreover, even a modest drop in plasma Glc concentration can decrease the capacity of the 
brain cells to take up Glc. Therefore, the body aims to maintain a steady circulating Glc level of 4-9 
mM, both in between and following meals (Gerich, 2000). This constitutes about 4 grams of Glc for 
a person weighing 70 kg (Wasserman, 2009). Depending on the organismal nutritional status, the 
human brain can consume 20-60% of the whole body’s Glc utilization in a resting state (Berg et al., 
2011; Erbsloh et al., 1958; Fonseca-Azevedo and Herculano-Houzel, 2012; Gerich, 1993), while most 
of the remaining body’s energetic needs are fulfilled by FFAs (Boden, 1997). 
2At the systemic level, Glc metabolism is coordinated by the interplay between the core metabolic
hormones: insulin and glucagon, while aberrances in their function often result in metabolic disorders.
In the anticipation of fluctuating nutrient availability, a subset of consumed dietary carbohydrates are
stored in the liver and skeletal muscles in the form of glycogen to be used in between meals. However,
following excessive intake of carbohydrates, another pathway is activated to help clear away Glc from
the circulation – lipogenesis, where the unneeded Glc is converted and thus trapped into
triacylglycerides (TAGs) (Ameer et al., 2014).
There are three main sources for plasma Glc: dietary carbohydrates, hepatic glycogenolysis (glycogen
breakdown) and gluconeogenesis (de novo synthesis of Glc from other metabolites; GlcNG). In
between meals and upon starvation, blood Glc is maintained steady mostly through rapidly
functioning glycogenolysis, and the slightly slower pathway of GlcNG (Ferrier, 2013). However,
upon dietary carbohydrate withdrawal, glycogen stores are sufficient to supply the body with Glc for
only 10 to 18 h (Ferrier, 2013). Moreover, after 40 h of fasting GlcNG will become the sole source of
Glc for the body, while all the able tissues will switch to lipid oxidation for energy utilization in order
to spare Glc for basal Glc-dependent processes (Soeters et al., 2012).
1.3 Carbohydrate metabolism
The digestion of carbohydrates starts nearly immediately after their consumption in the mouth saliva,
and after passing the stomach, is finalized in the small intestine (Dashty, 2013). Polysaccharides
composed of 6 carbon (C) units, like starch, are first hydrolyzed by the digestive enzymes, such as
amylases, and broken down to smaller fragments of oligosaccharides, and eventually to maltose in
the small intestine. Disaccharides, such as maltose, lactose, and sucrose are similarly first hydrolyzed
by their corresponding enzymes (maltase, lactase, and sucrase) into Glc and either Glc, Fru, or
galactose, respectively. The latter two can subsequently be converted into Glc in the liver (Dashty,
2013). The 5C sugars, including ribose and xylulose, readily diffuse through the absorptive cells of
the intestine. The 6C sugars are primarily imported by transporters that function either through an
active or facilitative mechanism. The active entry of hexoses requires Na+/K+-coupled pumps, while
the facilitated transport into the cell can occur through 14 different glucose transporters (GLUT1-14)
(Stringer et al., 2015) (Figure 1). The GLUTs display different tissue-specificity, affinity, and
capacity. Of these, GLUT4 is present in insulin-sensitive tissues and requires insulin-dependent
exocytosis to the plasma membrane (Stringer et al., 2015).
Once Glc has entered the cytoplasm of a cell, it is phosphorylated by hexokinases (HK, isoforms I-
IV), and results in the formation of Glc-6-phosphate G6P (Garrett and Grisham, 2016; Figure 1). This
is the first step of the universal Glc breakdown: glycolysis – a non-oxidative pathway. During this
process, one Glc molecule is broken down to two 3C molecules that are metabolized into two
molecules of pyruvate. Most of the reactions in this pathway are reversible upon sufficient substrate
concentrations, with the exception of three: the HK, the phosphofructokinase 1 and the pyruvate
kinase (PK) reactions (Berg et al., 2011).
Next, the formed pyruvate enters the mitochondrion via pyruvate translocase, and upon sufficient
oxygen conditions is decarboxylated by the pyruvate dehydrogenase (PDH) complex to form acetyl-
coenzyme A (AcCoA) (Figure 1). The latter enters the tricarboxylic acid (TCA) or the citric acid
cycle, by merging with oxaloacetate (OAA) to form citrate (Berg et al., 2011). The subsequent steps
in the pathway (as well as several previous reactions) will result in the reduction of nicotinamide
adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2), that subsequently donate
their electrons during oxidative phosphorylation to produce most of the adenosine triphosphate (ATP)
molecules derived from Glc oxidation. During hypoxic conditions however, the pyruvate from
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glycolysis is converted into lactate in the cytoplasm. This reaction is reversible upon re-oxygenation, 
whereupon the re-acquired pyruvate is metabolized through PDH (Garrett and Grisham, 2016). 
Alternatively, the G6P generated by HKs can enter the pentose phosphate pathway (PPP), where the 
first and the rate-limiting step is catalyzed by Glc-6-phosphate dehydrogenase (G6PD) (Figure 1). 
This cytoplasmic pathway produces nucleotide precursors in the form of ribose-5-phosphate (R5P) 
and reductive power through NADPH reduction. The latter is important in lipogenesis, and helps to 
maintain a proper antioxidant profile, including reducing glutathione (Puri, 2014). 
When high cellular energy levels result in excess ATP, the AcCoA formed by PDH accumulates, and 
slows down the TCA cycle. As an alternative output, the carbon backbones can enter de novo 
lipogenesis, mainly taking place in the liver. For this purpose, the abundant AcCoA exits the 
mitochondrion through interconversion to citrate (Figure 1). Next, cytosolic citrate is processed to 
form AcCoA and OAA. The re-formed cytoplasmic AcCoA is then carboxylated by the rate-limiting 
enzyme in lipogenesis – Acetyl-CoA carboxylase (ACC). The subsequent elongation steps are 
catalyzed by the Fatty acid synthase (FAS) requiring NADPH as the reductive power. As a result of 
this pathway, the excess sugar is converted into FFA that following esterification with glycerol-3-
phosphate (G3P), can be stored as TAGs (Berg et al., 2011). 
Likewise, following a meal, part of the excess G6P can also be stored in muscle and liver in the form 
of glycogen via glycogen synthesis (see Figure 1). The liver and muscle of an average person 
generally deposit 100 and 400 g of glycogen, respectively (Beck-Nielsen, 2012; Wasserman, 2009). 
Glycogen metabolism is heavily regulated, with the synthesis being stimulated by insulin, while 
breakdown is triggered by glucagon. In healthy subjects, about 80-90% of Glc taken up by the skeletal 
muscle is converted into glycogen, whereas in people suffering from type 2 diabetes, the percentage 
is reduced to 50%, thereby greatly contributing to diminished Glc disposal in these individuals 
(Højlund et al., 2003; Shulman et al., 1990). A noteworthy study analyzed the flux of Glc through 
different metabolic pathways: 37% was reported to be oxidized and exhaled as CO2, while 50% of 
Glc carbon backbones were converted into TAG (including 12% into glycerol and 88% into fatty 
acids). Of the remainder, 4.5% was converted into glycogen and 6.5% into lactate (Flatt and Ball, 
1964). 
1.3.1 Gluconeogenesis 
Fasting, low carbohydrate consumption, intense exercise, and a diabetic state can result in a shortage 
of intracellular carbohydrates. Such cues will activate gluconeogenesis (GlcNG) – an evolutionarily 
old pathway present in nearly all animals, fungi, plants, and bacteria (Berg et al., 2011; Nelson and 
Cox, 2012). GlcNG is a mainly cytoplasmic pathway producing Glc from other non-carbohydrate 
precursors, such as lactate, certain amino acids, and pyruvate. Some of the main tissues exhibiting 
GlcNG include the liver, kidney, brain, erythrocytes, and testes. During an overnight fast, about 85-
90% of the GlcNG takes place in the liver (Ekberg et al., 1999). The outline of GlcNG is similar to 
that of a reversed glycolysis, with the exception of four unique and highly regulated enzymes that 
substitute the irreversible reactions in glycolysis: pyruvate carboxylase, phosphoenolpyruvate 
carboxykinase (PEPCK); Fru-1,6 bisphosphatase (Fbp), and Glc-6-phosphatase (G6Pase) (Nuttall et 
al., 2008) (see Figure 1). 
Pyruvate carboxylase catalyzes the first step of the pathway: the conversion of pyruvate to OAA. The 
reaction consumes an ATP and a CO2 molecule, and takes place in the mitochondrion. Next, the 
formed OAA is transported to the cytosol in the form of malate via malate-aspartate shuttle, after 
which it is converted back to OAA (Dashty, 2013). Cytoplasmic OAA is used as a substrate by the 
cytoplasmic PEPCK (PEPCK-C). This step consumes a GTP molecule and results in the 
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decarboxylation of OAA, producing the high-energy intermediate phosphoenolpyruvate (PEP). Since 
PEPCK catalyzes the rate-limiting reaction of GlcNG, its metabolic role and regulation have received 
the most attention in this pathway (Nuttall et al., 2008). The next unique enzyme in GlcNG is Fru-
1,6-bisphosphatase, which results in the conversion of Fru-1,6-bisphosphate to Fru-6-phosphate. The 
final regulated step in GlcNG is the conversion of G6P to free Glc by G6Pase. In insects, the last step 
functions only in specific tissues such as testes, while the final product of GlcNG is mostly trehalose 
(Becker et al., 1996). 
 
Figure 1: Simplified illustration of main pathways metabolizing Glc. The Glc taken up into the cell 
is first phosphorylated by HK (isoforms I-IV), resulting in the formation of G6P. Depending on 
cellular nutritional status, G6P can either be metabolized further through PPP, glycolysis and TCA, 
or converted into glycogen. In addition, excess G6P results in the buildup of AcCoA, which can exit 
the TCA in the form of citrate, and be used as a substrate for lipogenesis. I-V depict the complexes of 
the respiratory chain. GA3P – glyceraldehyde-3-phosphate. Other abbreviations are explained in the 
main text. 
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1.3.2 Glyceroneogenesis  
In 1967, two independent groups described the synthesis of G3P in white adipose tissue (WAT) in 
what looked to be a shorter version of the GlcNG pathway (Ballard et al., 1967; Reshef et al., 1967). 
Soon thereafter, this stunted version of GlcNG was named glyceroneogenesis (GlyNG) (Gorin et al., 
1969), but its physiological relevance was not appreciated for several decades. GlyNG is known to 
take place in the liver and also in the adipose tissue, where its function has mostly been studied. Upon 
fasting, low carbohydrate diet, and prolonged exercise, the body will switch to using FFAs as the 
main energy source (Wolfe et al., 1990). This requires the hydrolysis of TAGs to FFAs and glycerol 
by lipases. However, a substantial fraction of the released FFAs will subsequently be re-esterified to 
re-form TAGs. The re-estrification is more frequent during the post-absorptive state, when up to 70-
90% of the released FFAs from lipolysis are esterified back to TAGs (Patel and Kalhan, 1992; Wolfe 
et al., 1990). While upon starvation, the re-esterification rate can drop down to 10-20% (Frayn and 
Humphreys, 2012; Wolfe et al., 1990). However, under fasting and low carbohydrate intake 
conditions, G3P cannot readily be synthesized from Glc. Moreover, the alternative pathway producing 
G3P through glycerol kinase has very low activity in the WAT (Reshef et al., 2003). Therefore, 
GlyNG is activated upon such conditions, mostly at the level of pepck transcription, to provide G3P 
for the recycling of excess FFAs that are released from the WAT upon lipolysis (Forest et al., 2003; 
Reshef et al., 2003). Surprisingly, GlyNG remains as the dominant source of glycerol incorporated 
into TAGs even with a high sucrose diet (Nye et al., 2008). This indicates that GlyNG is relevant not 
only during starvation, but also in well-fed conditions. 
1.3.3 PEPCK as the rate-limiting enzyme in GlcNG and GlyNG 
pepck-c is present as a single copy gene, but the genome of most organisms also contains another 
pepck variant – the mitochondrial PEPCK (pepck-m). Although pepck-m has been implicated in Glc 
homeostasis, it has been less studied than its cytoplasmic counterpart, and hence its role remains less 
understood (Stark and Kibbey, 2014). PEPCK-C functions as the pace-setting enzyme for both GlcNG 
and GlyNG. In mice, a two-fold increase in pepck-c levels leads to elevated hepatic Glc production 
(Sun et al., 2002), while a 7-fold expression results in hyperglycemia and insulin resistance (Valera 
et al., 1994). The importance of PEPCK-C in GlyNG, and as a result in lipid homeostasis, is illustrated 
by studies demonstrating that knock-down of this gene results in altered fat stores in C. elegans 
(Ashrafi et al., 2003). In addition, in mammals, overexpression of PEPCK-C in skeletal muscle 
increases localized fat content (Ren et al., 2017), while in the adipose tissue it leads to obesity due to 
increased FFA re-esterification (Franckhauser et al., 2002). As GlcNG contributes to Glc output more 
in diabetic patients than in control subjects (Wajngot et al., 2001), both mitochondrial and cytoplasmic 
PEPCK variants have been proposed to contribute to the development of type 2 diabetes (Beale et al., 
2007). Moreover, fasting levels of serum glycerol have been found to correlate with type 2 diabetes 
risk (Mahendran et al., 2013), and could hence be used as a prognostic marker. However, whether 
this is the consequence of over-active PEPCK and GlyNG, has not yet been studied. 
1.4 Consequences of excess Glc intake 
There is increasing amount of evidence to demonstrate the direct link between high levels of simple 
dietary sugars (such as Glc, and especially Fru), and increased incidence of weight gain, type 2 
diabetes and metabolic syndrome (reviewed in (Stanhope, 2012; Tappy and Lê, 2010). In addition, 
more recent results also demonstrate that even the excessive consumption of starches correlates with 
higher metabolic syndrome risk (Feng et al., 2015). An imbalanced diet high in carbohydrates can 
lead to hepatic steatosis – the first step in non-alcoholic fatty liver disease (NAFLD). Although it is a 
relatively benign condition, it can progress to non-alcoholic steatohepatitis (NASH). NASH may 
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further develop into such life-threatening conditions as cirrhosis or even liver cancer (Yki-Järvinen, 
2014). One of the contributors to pathologic sequence is the over-active de novo lipogenesis due to 
chronic excess of simple sugars. Moreover, the aftermaths of excessive sugar consumption, such as 
chronic hyperglycemia, obesity, and type 2 diabetes, in turn result in a higher risk to develop cancer 
(Gallagher and LeRoith, 2015). In addition, NAFLD and NASH are serious risk factors for the 
development of cardiovascular disease (CVD) – one of the main causes of mortality in these patients 
(Adams et al., 2017; Söderberg et al., 2010).  
1.4.1 Hyperglycemia as an inducer of oxidative stress 
About 3% of Glc is present in solution in its linear aldehyde form, making it a reducing sugar. 
Consequently, it can readily react, in a non-enzymatic manner, with amino-groups present in proteins 
leading to their inadvertent glycation. This process may escalate and result in the following protein 
alterations: cross-linking, aberrant conformation, and changed flexibility – all due to the formation of 
advanced glycation end-products (AGEs) (Wautier and Schmidt, 2004). As a result of chronic 
hyperglycemia, AGEs become more prevalent. AGEs, however, are potent inducers of reactive 
oxygen species (ROS), and inflammation (Giacco and Brownlee, 2010). In fact, the level of 
hemoglobin glycation from a blood test is routinely used to assess the extent of hyperglycemic 
damage.  
In addition, hyperglycemia and consequently increased intracellular Glc levels have been 
demonstrated to lead to elevated ROS generation by mitochondria (Du et al., 2001). Another 
contributor to increased oxidative stress upon hyperglycemia is the activation of the polyol pathway. 
Upon high intracellular Glc levels, alternative metabolic pathways, such as the polyol pathway, 
become activated to aid in Glc clearance. As a result of hyperglycemia, up to 30% of Glc can be 
channeled into the polyol pathway (Cheng and González, 1986). The first enzyme in the pathway, 
aldose reductase, converts Glc into an inactive alcohol sorbitol by consuming NAPDH. Upon 
chronically high Glc levels, this step consumes significant amounts of NADPH. The latter, however, 
is the central cellular reductive power required for reducing the critical antioxidant glutathione 
disulfide (GSSG) into glutathione (GSH). As sorbitol is osmotically active, and high levels of it can 
damage cells, additional steps are important to metabolize it further. The second step in the polyol 
pathway is catalyzed by sorbitol dehydrogenase, and converts sorbitol into Fru by reducing NADH. 
Both steps of the pathway have been demonstrated to contribute to hyperglycemia-induced oxidative 
stress in the lens and nerves (Chung et al., 2003). In sum, Glc stress leads to elevated levels of ROS, 
and decreased levels of a vital antioxidant. As a consequence, high Glc will expose the body to 
increased levels of oxidative stress and also hamper its ability to alleviate it. 
1.5 Circadian rhythm and metabolic homeostasis 
The phrase “circa diem” (in Latin) translates into “about a day”. Accordingly, the term circadian 
rhythm is used to characterize the oscillations observed in organismal sleep-wake cycle, behavior, 
and feeding that occur in a distinctive daily pattern. As the length of a day can differ substantially due 
to seasonal changes, the intrinsic ability of the circadian clock is to ensure flexibility and adaption to 
environmental cues, while at the same time preserving inherent cycling upon loss of such stimuli 
(Edery, 2000). 
In vertebrates, the so-called central and the peripheral clocks can be distinguished that are nevertheless 
heavily interconnected. The central clock located in the suprachiasmatic nuclei in the mammalian 
brain functions as a pacemaker to relay the information of external light to peripheral clocks, to ensure 
in-phase activity with the environment (Ray and Reddy, 2016). In the fruit fly, where many of the 
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core clock components were first characterized, only the peripheral clocks exist, as the information 
from external light can be passed on not solely through the optic nerve, but virtually by the whole 
body, hence making the synchronization of the peripheral clocks by the central light-regulated clock 
unneeded (Hardin, 2011). 
Suggestive evidence for a role of circadian rhythm in the regulation of metabolic homeostasis has 
been present for decades, as a clear correlation between shift workers and increased risk for metabolic 
disorders has been documented (De Bacquer et al., 2009). Moreover, it has been suggested that in 
addition to external light, the circadian clocks are sensitive to eating and could thereby be entrained 
by food (Stokkan et al., 2001). For example, a high calorie diet rich in fats has been shown to disrupt 
the circadian rhythm in mice (Kohsaka et al., 2007). Curiously, the expression of many metabolic 
genes is known to oscillate throughout the day, apparently in the anticipation of nutrient consumption 
or overnight fasting (Vollmers et al., 2009). This may prove to be the underlying explanation of why 
shift workers experience more metabolic disorders, as their innate circadian rhythms contradict 
anticipated feeding patterns. Hence, signaling pathways facilitating information about nutritional 
status and clock cycling are expected to contribute to metabolic homeostasis maintenance. 
Although transcription-independent processes, such as phosphorylation and redox changes have been 
discovered to have a role in circadian rhythm (Kil et al., 2015; Robles et al., 2017), at the heart of the 
molecular clock lies a transcriptional loop orchestrated by autoregulation and feedback mechanisms. 
The mammalian and the fruit fly circadian clocks have several homologous components. For the 
purpose of this thesis, the Drosophila molecular clock and its main constituent genes are briefly 
introduced. 
The circadian feedback loop in Drosophila is composed of 
transcription factors (TFs) dClock (dClk; CLOCK in mammals) 
and Cycle (Cyc; BMAL1 in mammals) that function as a dimer to 
bind E-box elements present in their target gene promoters. As a 
result, clock-controlled genes (CCG), including period (per), 
timeless (tim), PAR domain protein 1 ε (PDP1ε), and vrille (vri) 
are expressed (Hardin, 2011; Figure 2). Per and Tim proteins 
accumulate in the cytoplasm, while they undergo phosphorylation 
to enter the nucleus, where they function as a complex. Once 
sufficient amount of Per-Tim have accumulated in the nucleus, 
Figure 2: Overview of central circadian 
regulators and their time-dynamic 
processes in Drosophila. Circadian gene 
oscillations are ensured by fluctuating light 
conditions, as well as delays in 
transcription and phosphorylation-
triggered processes. The molecular clock in 
the fly is composed of TFs Cyc and dClk, 
which form dimers on clock-controlled gene 
(CCG) promoters. In response to their 
transcriptional activity, Per and Tim 
proteins accumulate in the cytoplasm, 
before they are phosphorylated. They 
subsequently enter the nucleus, where the 
Tim-Per dimer will directly inhibit the 
activity of Cyc-dClk. 
Figure 3: Gene expression 
oscillation of a CCG, 
depending on the time of day 
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they promote dClk phosphorylation, leading to repression of the dClk-Cyc dimer activity, and hence 
their own expression. Over time, the Per protein accumulates a critical number of phosphorylations 
in the nucleus, demarking it to be degraded in the proteasome. In parallel, as Tim is sensitive to light-
triggered degradation, its protein levels oscillate according to the time of day (Peschel and Helfrich-
Förster, 2011). In addition, the CCG PDP1ε promotes the transcription of dClk, while Vri represses 
it (Figure 2). This intertwined transcriptional loop with periodic exposure to light, delays in protein 
translation, (de-) phosphorylation, and degradation is responsible for the cycling of CCGs that 
oscillate during 24 h (for example, see Figure 3). 
1.5 Fruit fly as a model to study metabolism 
Drosophila melanogaster has been implemented in genetic research for over a century (Morgan, 
1910). The advantages of this Dipteran model organism include low cost, compact genome, fast life 
cycle, and broad selection of available genetic tools. More importantly, a majority of human disease-
causing genes have an identified homolog in Drosophila (Chien et al., 2002). In addition, many 
duplicated genes in humans exist as a single copy in the fly, considerably simplifying the aspect of 
redundancy. Many critical pathway components have first been uncovered in the fly, leading to the 
subsequent homology-based identification in mammals. The first circadian gene period and its mutant 
were first described in Drosophila (Konopka and Benzer, 1971), opening up a whole new field with 
studies leading to the identification of the underlying circuit of circadian control. 
Balancer chromosomes harboring extensive inversions and genetic markers have been generated to 
prevent recombination, and to aid in lethal stock maintenance (Casso et al., 1999). Moreover, a 
selection of transposable element insertion mutant stocks are commercially available. These lines may 
present aberrant expression of a given gene of interest, or alternatively, can be used for imprecise 
excision-mediated deletion mutant generation (Ryder and Russell, 2003). The genome editing 
approach based on CRISPR/Cas9 has successfully been implemented in the fly, thereby greatly 
increasing the number of possible genetic manipulations (Beumer and Carroll, 2014). The adaption 
of the upstream activating sequence (UAS) – galactose gene transcription factor 4 (GAL4) system in 
Drosophila has offered a genetic advantage to temporally and tissue-specifically modulate gene 
Figure 4: The outline of Drosophila life 
cycle. At 25 °C, it takes an average of 10 
days for a fly to develop from an egg to 
adult. Females are sexually mature after 
emerging, while males need about 8 h to 
be able to mate. The eggs are laid 
approximately a day after mating. The 
larval phase is divided into three instars. 
Molting occurs between the 1st and 2nd, 
as well as before the 3rd instar stage. The 
final larval instar stage is followed by a 
“wandering” phase, and subsequent 
pupariation. This marks the start of 
metamorphosis, which takes place in the 
pupal case. After about three days, the 
larval tissues have been reorganized into 
adult counterparts, and the fly emerges 
from the pupal case in a process termed 
eclosion. 
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expression (McGuire et al., 2003). Currently, several stock centers exist to provide a near complete 
coverage for RNA interference (RNAi) constructs (Dietzl et al., 2007; Kaya-Çopur and Schnorrer, 
2016; Perkins et al., 2015). Due to commercial services, the generation of transgenic flies has become 
more efficient and faster, with an average wait of about 2 months for balanced lines. 
The life cycle of the fly is short, yet can be modified according to experimental needs by adjusting 
the temperature between 18 and 29° C. At the optimal temperature of 25° C, it takes approximately 
10 days for an egg to develop into an adult (Figure 4). During the three larval instars, the animal will 
feed continuously until it leaves the food for a “wandering” stage preceding the pupariation. The 
metamorphosis lasts several days and relies on pre-existing energy storage. The end of the pupal phase 
is called the pharate adult stage, where the animal will obtain its final morphology inside the pupal 
case. This is followed by eclosion – the emergence of adult flies. In contrast to larvae, adult flies are 
intermittent feeders, and display circadian clock-dictated bimodal activity in their rhythmic behavior 
(Peschel and Helfrich-Förster, 2011).  
Due to a high level of conservation in signaling pathways, Drosophila is becoming an increasingly 
relevant model organism to study growth, and nutritional homeostasis. For example, the mechanism 
of insulin signaling has remained conserved throughout evolution, and thereby the outline is 
comparable in flies and mammals. The Drosophila genome encodes for 8 insulin-like peptides (dILPs 
1-8), and two receptors (Drosophila insulin receptor, and Leucine-rich repeat-containing G protein-
coupled receptor 3). Notably, only dILPs 2, 3, and 5 are produced and released by the neurosecretory 
cells (insulin producing cells) situated in the brain (Nässel and Vanden Broeck, 2016). 
Drosophila melanogaster, as a food generalist, can be reared on a variety of different diets. This 
enables manipulation of nutrient levels to investigate their different metabolic aspects. Moreover, 
numerous well-established methods have been developed to assess metabolic profiles in the fly 
(Tennessen et al., 2014). The fly intestinal system shows several similarities to mammalian 
counterparts, both in terms of structure, tissue, and physiology (Apidianakis and Rahme, 2011). 
Similar to mammals, inter-organ communication is crucial for fly metabolic homeostasis (Ugur et al., 
2016). In flies, the equivalents of the adipose tissue and liver are fat body and oenocytes, while 
Malpighian or renal tubules function as kidneys. The fat body is central for coordinating metabolic 
sensing, and is largely composed of lipid-containing cells, but also stores glycogen. In the larval stage, 
the fat body is mainly present as an elongated cluster of cells in the abdomen. During metamorphosis, 
the fat body is broken down through autophagy and regenerated anew, resulting in the redistribution 
of the tissue. Consequently, in adults, part of the fat body is located around the brain, while the 
majority remains in the abdomen (Hwangbo et al., 2004). The uptake of simple sugars from the food 
occurs passively through the digestive tract into the hemolymph, followed by channeling to the fat 
body. Once there, Glc is converted into trehalose – a Glc-dimer and the most abundant circulating 
carbohydrate in insects (Graham and Pick, 2017). For comparison, there is approximately 100-times 
more trehalose in the fly than Glc.  
1.6 Glc-elicited transcriptional response  
1.6.1 Carbohydrate response element 
Promoter components responding to cellular Glc levels were first investigated more thoroughly for 
the L-PK and S14 genes (Shih and Towle, 1994, 1992; Shih et al., 1995; Thompson and Towle, 1991). 
Through such pioneering studies by the Towle laboratory, the term carbohydrate-response element 
(ChoRE) was coined. Further mapping revealed a consensus sequence in the form of two Enhancer 
box or E-box elements (CACGTG) spaced by 5 nucleotides: CACGTGnnnnnCACGTG. It is 
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noteworthy that mutations changing the spacer region length reduce (6 base pair [bp]) or abolish (4 
bp) the Glc-responsiveness (Shih et al., 1995). Since then, ChoREs have been identified in the 
promoters of many lipogenic and glycolytic genes (Ma et al., 2006; Mattila et al., 2015; Rufo et al., 
2001; Shih et al., 1995). Further experiments have revealed tolerable aberrances from the perfect 
ChoRE sequence, while still maintaining carbohydrate responsiveness (Kaytor et al., 1997; Ma et al., 
2006; Mattila et al., 2015). In addition, the relative orientation of the two E-boxes in a non-perfect 
ChoRE may be of critical importance, as their exchanging can result in dramatically different Glc-
responsiveness (Kaytor et al., 1997). 
E-boxes are well known consensus motives for basic helix-loop-helix (bHLH) leucine zipper (LZ) 
TFs that bind the DNA element as obligate dimers or tetramers (Prendergast and Ziff, 1991). Given 
that an ideal E-box element is palindromic, one of the protein monomers attaches to the CAC triplet 
from one strand, while the other to the CAC from the other strand (Massari and Murre, 2000). In 
2001, the transcription factor consequently named carbohydrate response element binding protein 
(ChREBP) was shown to bind these elements in a sugar-dependent manner (Yamashita et al., 2001). 
By using affinity chromatography, ChREBP was purified as one of the proteins binding the ChoRE 
in the PK gene promoter. Moreover, in response to feeding rats with a high carbohydrate diet, the 
DNA-binding of ChREBP increased in liver cells, and correlated with ChoRE-containing promoter 
reporter activity (Yamashita et al., 2001). For a representation of ChoRE-motif consensus sequence 
bound by ChREBP, see Figure 5. 
 
(Poungvarin et al., 2015) 
Since their discovery almost two decades ago, the Mondo family of bHLH LZ TFs has quickly been 
established as key-mediators of sugar-dependent transcriptional control (Havula and Hietakangas, 
2012). In mammals, two paralogous Mondo proteins exist: MondoA, and MondoB - better known as 
ChREBP. In order to enter the nucleus and regulate the expression of Glc-responsive genes, both 
Mondo proteins require dimerization with another bHLH LZ TF: Mad-like protein X (Mlx) (Bellwood 
et al., 2007; Eilers et al., 2002; Peterson et al., 2010; Stoltzman et al., 2008).  
Mlx belongs to the Myc/Max/Mad TF family, and was first discovered from a yeast-two hybrid assay 
in a search for Mad-family-interacting proteins (Mlx) (Billin et al., 1999). mlx is a highly expressed 
gene displaying a ubiquitous tissue-level distribution pattern (Billin et al., 1999; Meroni et al., 2000). 
Three alternatively spliced variants of Mlx have been characterized (α, β, γ) that do not display an 
obvious tissue specificity (Meroni et al., 2000). The Mlx protein has a low molecular weight of 30 
kilo-Dalton (kDa), and due to its long half-life (6-8 h), displays relative stability. 
MondoA was first identified through a yeast two-hybrid screen for new Mlx-interacting partners 
(Billin et al., 2000), and therefore, in databases its gene is mainly referred to as mlx interacting protein 
(mlxip). The mlxip gene expression is detected in most adult tissues, while skeletal muscle displays 
the highest levels (Billin et al., 2000). Due to the presence of a cytoplasmic localization domain in 
MondoA, MondoA-Mlx complex displays a mainly cytoplasmic localization pattern (Billin et al., 
2000). In fact, in many cell types, MondoA-Mlx dynamically shuttle between the nucleus and the 
outer mitochondrial membrane (Sans et al., 2006). Such behavior has been suggested to facilitate 
Figure 5: A representation of a 
ChoRE motif. This illustration is 
based on ChreBP-dependent 
chromatin immunoprecipitation 
(ChIP), followed by sequencing 
experiments. Modified from 
Poungvarin et al., 2015. 
1.6.2 The sugar sensing TF complexes MondoA Mlx and ChREBP Mlx 
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communication between the mitochondria and the nucleus, thereby helping to maintain cellular 
energy homeostasis. 
ChREBP/MondoB was discovered based on database comparisons to MondoA, and the gene was 
subsequently named as mlx-interacting protein like (mlxipl) (Billin et al., 2000). The ChREBP-Mlx 
interaction was independently confirmed though a yeast two-hybrid screen (Stoeckman et al., 2004). 
In contrast to Mlx, the ChREBP protein displays a relatively shorter half-life of 30 min (Cairo et al., 
2001). As the ChREBP protein is larger than the cut-off value of 45 kDa for passive transport to the 
nucleus (Jans and Hübner, 1996), it requires a nuclear localization signal to enter, or an interacting 
protein possessing one. Motif analysis has revealed the presence of a bipartite nuclear localization 
signal (NLS) that shows very high level conservation (de Luis et al., 2000). Interestingly, the longer 
Mlx, rather than the ChREBP protein loop domain, determines the response to Glc by interacting with 
ChoRE (Ma et al., 2006, 2007). 
Through genome-wide association studies in humans numerous polymorphisms in both mlxip and 
mlxipl have been characterized. Curiously, several mlxipl single nucleotide polymorphisms have been 
associated with metabolic alterations, such as hypertriglyceridemia, and an increased risk to develop 
NAFLD and metabolic syndrome (reviewed in Richards et al., 2017). Moreover, the majority of 
people suffering from Williams-Beuren syndrome, a disease caused by a microdeletion covering 26-
28 genes, inlcuding mlxipl, display impaired Glc tolerance (Pober, 2010).  
1.6.2.1 Structure of Mlx and the Mondo-proteins 
The C-terminal domains of Mlx and both Mondo proteins display clear similarities, potentially 
pointing to evolutionary ancestry (Billin et al., 2000). All three TFs possess a dimerization and 
cytoplasmic localization domain (DCD) (Figure 6). The interaction with DNA is facilitated by the 
LZ and bHLH domains.  
MondoA and ChREBP are big multi-domain proteins with shared structural characteristics. The N-
terminal region contains the evolutionarily conserved Glc-sensing module (GSM), composed of low-
Glc inhibitory domain (LID), and Glc-response activation conserved element (GRACE) (Havula and 
Hietakangas, 2012) (Figure 6). Strikingly, a 1-196 aa deletion variant of ChREBP results in a 
constitutively active transcriptional regulator, independent of Glc levels and loss of NLS. This 
phenomenon has been explained by the intramolecular interaction proposed to take place between 
LID and GRACE. More specifically, LID is believed to repress GRACE activity under low Glc 
conditions through a hinge-like conformational mechanism (Davies et al., 2010; Ma et al., 2006). 
Upon increased Glc conditions, however, an allosteric conformational change is proposed to occur, 
leading to de-repression of GRACE by LID, resulting in the Glc-dependent activation of the 
transcription factor. Based on modelling studies, a highly conserved G6P-recognition motif has been 
predicted to reside in the GRACE domain of Mondo proteins (McFerrin and Atchley, 2012). G6P 
binding by Mondo-proteins has been suggested to result in an allosteric conformational change that 
leads to an open complex where LID is unable to hinder GRACE activity. Consequently, the interplay 
between LID and GRACE functions as a Glc-sensing switch, by being sensitive to the central Glc 
metabolite – G6P. The extent of GSM conservation is further highlighted by the fact that Glc-
responsiveness was retained upon an exchange between the two Mondo proteins, and even by using 
the same domain from the Drosophila orthologue (Ma et al., 2006). 
In 2012, a shorter, alternatively spliced variant of ChREBP was identified from adipose tissue, and 
named ChREBPβ, as opposed to the full length protein - ChREBPα (Herman et al., 2012). The 
alternative promoter of ChREBPβ contains a ChoRE element in the alternative first exon, and thus its 
expression depends on ChREBPα. As the first exon of ChREBPα containing the translation start site 
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is skipped, the ChREBPβ protein coding sequence starts from exon 4, resulting in 177 aa shorter 
isoform. Consequently, ChREBPβ lack most of the LID, while retaining an intact GRACE (Figure 
6). As a result, ChREBPβ displays similar transcriptional activity both under low and high Glc 
conditions, and is approximately 20 times more potent than the full length isoform (Herman et al., 
2012) – a behavior more similar to the constitutively active ChREBP mutant lacking the first 196 aa. 
Therefore, the activation of ChREBPα by high Glc will trigger the expression of a more potent 
isoform that further amplifies the response to sugar. However, due to the lack of most of the N-
terminal domain, and hence loss of stabilizing protein interactions, ChREBPβ may have an even 
shorter half-life than 30 minutes. 
Close analysis of the Mondo protein sequences between different species has revealed the presence 
of five Mondo-conserved regions (MCRI-V) in the N-terminus (Billin et al., 2000; Davies et al., 2008; 
Eilers et al., 2002) (Figure 6). Specific roles and interaction partners for some of the MCRs have been 
characterized. For example, MCRII functions as a CRM1 dependent nuclear export signal (NES), 
while MCRIII contains a 14-3-3 biding site – both interactions are important for cytoplasmic 
localization (Eilers et al., 2002). In addition, MCR IV had been demonstrated to function as an NLS. 
Notably, the spacing between MCR II, III, and IV in Mondo proteins is identical between metazoans, 
potentially suggesting the presence of a functional unit. However, the spacing of neighboring regions 
differs between MondoA and ChREBP. As a result, mutations of individual MCRs have different 
outcomes on MondoA and ChREBP activity (Peterson et al., 2010). 
 
1.6.2.2 Evolution and conservation of Mlx and the Mondo proteins 
Sequences resembling Mlx and Mondo have been identified from even some of the smallest genomes 
of some of the simplest known animals, such as Trichoplax adherens (McFerrin and Atchley, 2011; 
Srivastava et al., 2008). This underlines the ancient ancestry of Mlx and Mondo proteins that 
seemingly predates the origin of animals around 500 million years ago (McFerrin and Atchley, 2011). 
Moreover, sequences resembling the GSM region of the Mondo proteins seem to be metazoan-
specific, possibly indicating that these TFs evolved to coordinate communication between organs for 
whole body homeostasis maintenance (Richards et al., 2017). 
Evolutionary comparison studies have revealed that MondoA and ChREBP are the divergence 
products of a duplication event that occurred either prior or during early vertebrate evolution (Dehal 
and Boore, 2005; McFerrin and Atchley, 2011; Singh and Irwin, 2016). This is illustrated by the 
Figure 6: The structural outline 
of Mlx and Mondo proteins. All 
TFs have a similar C-terminal 
domain. The Mondo-conserved 
regions are marked with roman 
numbers. ChREBPβ is an 
alternatively spliced variant that 
lacks the LID domain present in 
MondoA and ChREBPα. NES – 
nuclear export signal. Proteins not 
drawn to scale. Modified from 
Filhoulaud et al., 2013 and 
Havula and Hietakangas, 2012. 
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presence of Mlxip and Mlxipl genes in nearly all vertebrates, with an apparent degree of overlapping 
synteny. In accordance with this, the genome of invertebrate animals, including C. elegans and D. 
melanogaster, encodes for a single Mondo protein. Despite multiple genome duplication events at the 
time of early vertebrate evolution, all examined species among the phylum Chordata harbor only a 
single gene for mlx (McFerrin and Atchley, 2011). This may indicate a high natural selection for the 
regulation of single functional copies and coordinated interactions (McFerrin and Atchley, 2011; 
Singh and Irwin, 2016). 
Comparisons of the two Mondo proteins in mammals have revealed a stronger selection pressure on 
the MondoA protein, in comparison to ChREBP, in all regions except the DCD. This may indicate a 
more ancient and evolutionarily a more critical function for MondoA (Singh and Irwin, 2016). In 
addition, in contrast to fish, tetrapods possess an alternative, auto-regulatory isoform of ChREBP 
(ChREBP-β), demonstrating the development of a more recent control (Singh and Irwin, 2016). 
1.6.2.3. Regulation of MondoA and ChREBP 
1.6.2.3.1 Glc-sensing through intermediary metabolites 
Due to their high level of similarity, the regulation of MondoA and ChREBP activity displays several 
common features. However, many differences have also been reported. Despite extensive studies, the 
exact mechanism of how MondoA and ChREBP are activated in response to sugars, remains poorly 
understood. Three carbohydrate metabolism intermediates have been implicated to facilitate the 
information about intracellular Glc levels to modulate MondoA and ChREBP activity. These include 
xylulose-5-phosphate (Xu5P), G6P, and Fru-2,6 bisphosphate (F2,6P).  
Based on experimental evidence, Xu5P was demonstrated to activate the necessary PP2A-family 
phosphatases, catalyzing the removal of the critical phosho-groups from AMP-activated kinase 
(AMPK) and cyclic adenosine monophosphate (cAMP)-dependent kinase (PKA) target sites (S196, 
S568 and T666), and thus resulting in ChREBP nuclear translocation and increased DNA-binding 
(Kabashima et al., 2003) (Figure 7). However, nuclear localization has been shown to be insufficient 
for MondoA-Mlx transcriptional activation, as it does not lead to increased promoter occupancy 
(Peterson et al., 2010). Therefore, G6P has been proposed as the more dominant metabolite in 
facilitating ChREBP and MondoA activation (Li et al., 2010; Peterson et al., 2010; Stoltzman et al., 
2008) (Figure 7). HK - enzymes generating G6P, were demonstrated to be crucial for MondoA 
activation (Stoltzman et al., 2008). G6P has also been demonstrated to be sufficient for ChREBP-Mlx 
nuclear translocation and activation (Dentin et al., 2012; Li et al., 2010). Moreover, a putative G6P-
recognition motif has been predicted to reside in the GRACE domains of Mondo proteins (McFerrin 
and Atchley, 2011). However, experimental evidence of direct G6P binding by Mondo proteins is 
currently lacking. In addition to G6P, another glycolytic intermediate has been linked to activating 
Mondo proteins: F2,6P (Figure 7). This metabolite is an allosteric activator of glycolysis, and 
inhibitor of GlcNG (Hue and Rider, 1987). Notably, F2,6P has been demonstrated to facilitate 
ChREBPs sugar-induced translocation to the nucleus in liver cells. Moreover, suppressing F2,6P 
production downstream of G6P, decreases target gene promoter occupancy by ChREBP-Mlx in 
hepatocytes (Arden et al., 2012). Similarly, the importance of F2,6P in hepatocytes has also been 
demonstrated for MondoA-Mlx recruitment to target gene promoters (Petrie et al., 2013). This may 
indicate the presence of conserved regions between MondoA and ChREBP that facilitate F2,6P 
sensing. In sum, it is possible that several metabolites delegate the Glc-induced activation of Mondo 
proteins. Currently, the most convincing data point to G6P being the primary link between increased 
intracellular Glc levels and MondoA/ChREBP-Mlx activity. 
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1.6.2.3.2 Inhibitors of MondoA/ChREBP-Mlx activity 
Numerous reports exist to point to an intricate regulation of MondoA/ChREBP-Mlx by different 
pathways. However, successive studies have made certain discrepancies in published results apparent. 
Thus, further research is needed to help understand the underlying mechanisms of MondoA/ChREBP-
Mlx regulation. 
To date, several key metabolic kinases have been demonstrated to phosphorylate ChREBP. For 
example, there are at least three PKA phosphorylation consensus sites in the ChREBP protein, of 
which Ser196 and Thr666 were confirmed to be critical in regulating nuclear localization and DNA-
binding ability (Kawaguchi et al., 2001; Yamashita et al., 2001). In vitro experiments demonstrated 
that PKA-dependent phosphorylation inhibits the ChREBP DNA-binding ability by 90%, which can 
partially be rescued by the addition of the phosphatase PP2A (Yamashita et al., 2001) (Figure 7). 
However, other research groups have observed only modest effects on nuclear localization upon 
mutating these phospho-sites (Eilers et al., 2002; Ma et al., 2006). Moreover, as these supposed Glc-
sensitive phospho-sites are not conserved in MondoA or in the Drosophila Mondo protein (Billin and 
Ayer, 2006; Ma et al., 2005), additional mechanisms than nuclear localization determinants relaying 
Glc-responsiveness are believed to exist.  
As carbohydrate metabolism lies at the center of cellular metabolic homeostasis, reciprocal regulation 
through organismal nutritional status would be expected to occur. In agreement with this, metabolites 
increased upon starvation, such as acetate and certain ketone bodies, have been found to inhibit 
ChREBP-Mlx activity (Kawaguchi et al., 2002; Nakagawa et al., 2013). In addition, certain saturated 
and unsaturated fatty acids also potently reduce ChREBP-Mlx nuclear translocation (Dentin et al., 
2012; Kawaguchi et al., 2002; Sato et al., 2016). The underlying mechanism of this inhibition depends 
on increased AMP levels. Due to allosteric binding, AMP promotes the interaction between ChREBP 
and 14-3-3, and subsequent cytoplasmic sequestration (Sato et al., 2016) (Figure 7). 
In addition, in response to elevated AMP levels, the AMPK has been proposed to inhibit ChREBP 
function. Ser568 in ChREBP was mapped as the kinase target site that upon phosphorylation leads to 
the inactivation of DNA-binding ability (Kawaguchi et al., 2002) (Figure 7). However, consecutive 
studies revealed that the regulatory understanding based on PKA and AMPK regulations is 
incomplete, as additional ChREBP-Mlx activating steps are required for full high-Glc response 
(Stoeckman et al., 2004). 
 
Figure 7: Examples of regulatory 
mechanisms affecting Mondo 
proteins, illustrated on ChREBP. AMP 
has been demonstrated and G6P is 
proposed to regulate the TF complex 
activity through allosteric binding. In 
addition, several post-translational 
modifications affecting nuclear 
localization, stability and DNA-binding 
have been reported. See main text for 
details. 
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1.6.2.3.3 Post-translational activation of ChREBP 
In addition to phosphorylation, ChREBP is subjected to other types of post-translational modifications 
that affect its activity. For example, ChREBP is reported to be acetylated by the histone 
acetyltransferase co-activator p300 (Bricambert et al., 2010) (Figure 7). The acetylation of Lys672, 
that is located in the DNA-binding domain, increases ChREBP-Mlx DNA-binding, and thereby 
promotes target gene expression. Notably, however, p300 is subjected to Salt-inducible kinase (SIK) 
2-dependent inhibitory phosphorylation (Bricambert et al., 2010) (Figure 7). Therefore, SIK2 
silencing in liver retains p300 activity, and promotes increased ChREBP-Mlx target gene expression, 
resulting in hepatic steatosis. As SIK2 activity has been demonstrated to be influenced by the 
organismal nutritional status (Du et al., 2008), it likely functions to coordinate metabolic needs by 
modulating ChREBP-Mlx activity through p300. 
Secondly, ChREBP interacts with and is targeted by the O-linked N-acetyl-glucosamine (GlcNAc) 
transferase enzyme (OGT). Moreover, the GlcNAc-modifed ChREBP displays higher protein stability 
and increased transcriptional activity towards its target genes (Guinez et al., 2011) (Figure 7). As 
GlcNac synthesis is limited to the availability of its substrates, Glc and Fru, this may add an additional 
hexose-regulated mechanism layer to ChREBP function. However, it has not yet been investigated 
whether MondoA is similarly targeted by OGT. 
In sum, numerous metabolites, as well as signaling pathways, have been demonstrated to regulate the 
MondoA/ChREBP-Mlx complex (Figure 7). The large number of regulators may indicate a central 
role at the metabolic nexus for ChREBP/MondoA-Mlx. However, much detailed information about 
these regulatory mechanisms remains unclear. Moreover, it is highly likely that other, as yet 
uncharacterized, regulatory processes exist to fine-tune ChREBP/MondoA-Mlx activity.  
1.6.2.4. Target genes and physiological output 
1.6.2.4.1. Interplay between the two Mondo proteins 
ChREBP expression is most abundant in the liver and adipose tissue, while MondoA in its ubiquitous 
pattern shows the highest levels in the skeletal muscle. Consequently, it has been thought that the 
paralogs have diverged to regulate sugar-responsive gene expression in their respective tissues. 
However, experimental evidence suggests that MondoA has specific functions also in the liver (Ahn 
et al., 2016; Petrie et al., 2013), while ChREBP-dependent gene expression regulation is important in 
metabolic type determination in muscle fibers (Hanke et al., 2011). Despite their vast structural 
similarity and responsiveness to Glc, very few shared direct target genes have been identified to date. 
In addition to tissue-specific differences, this may be partially explained due to recognized promoter 
elements. ChREBP-Mlx have been demonstrated to bind the ChoRE elements, composed of two E-
boxes, spaced with 5 critical nucleotides. The two E-boxes are each recognized and bound by a 
heterodimer, resulting in the formation of a ChREBP-Mlx tetramer that is sensitive to the spacer 
region length. Such multimeric ChREBP-Mlx complexes have experimentally been demonstrated to 
form at certain target gene promoters. Although ChREBP-Mlx dimers are able to bind to single E-
box elements, albeit more weakly, such reporters fail to respond to Glc (Ma et al., 2007). Simultaneous 
binding of two E-boxes instead of one is believed to stabilize the interaction of ChREBP-Mlx with 
more degenerate and less perfect elements. In contrast, several identified MondoA-Mlx targets have 
one or several consecutive E-box elements in their promoters, and not necessarily a full ChoRE 
element (Sans et al., 2006). The exceptions here are the ChoRE elements in the thioredoxin interacting 
protein (TXNIP) and arrestin domain containing protein 4 (ARRDC4) promoters (Parmenter et al., 
2014; Stoltzman et al., 2008) – two paralogous genes with overlapping function in inhibiting Glc 
uptake. The former gene has also been identified as a target of ChREBP (Cha-Molstad et al., 2009). 
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Based on functional conservation, the paralog ARRDC4 may also be a target of ChREBP, but this 
has not yet been experimentally reported (Peterson and Ayer, 2011). It is thus possible that a single 
E-box element is sufficient for MondoA-Mlx mediated transcriptional response, while TXNIP (and, 
possibly ADDRC4) promoter is a hybrid version capable of sustaining regulation by both ChREBP 
and MondoA. 
1.6.2.4.2. MondoA-Mlx regulate glycolysis and Glc uptake 
Experiments conducted in myoblast and kidney cells have helped uncover a dual role for the MondoA-
Mlx complex in Glc metabolism. Particularly, through its target genes, MondoA has been found to 
promote the rate of glycolysis (Sans et al., 2006), while simultaneously inhibiting further Glc uptake 
(Stoltzman et al., 2008). Several genes related to glycolysis, including HKII (see Table 1), have been 
identified as direct targets of MondoA-Mlx in myoblasts. However, other reports have contradicted 
the proposed correlation between increased MondoA activity and higher glycolytic rate. For example, 
it has been reported that the glycolytic rate in skeletal muscles of mice lacking MondoA was in fact 
increased, while Mlx-dependent glycolytic gene expression regulation was not apparent in muscle 
precursor cells (Hunt et al., 2015; Imamura et al., 2014).  
The MondoA-dependent inhibition of Glc uptake occurs through direct Glc-dependent upregulation 
of TXNIP and ARRDC4 (Parmenter et al., 2014; Stoltzman et al., 2008, 2011). TXNIP and ARRDC4 
are paralogs belonging to the same protein family (Patwari et al., 2009). The fact that these genes 
inhibit further Glc uptake, illustrates the presence of a feedback loop through modulation of MondoA-
Mlx activity. In addition, inhibiting MondoA activity in liver and skeletal muscle has been linked to 
lower TAG synthesis due to reduced lipogenic gene expression (Ahn et al., 2016). MondoA has also 
been demonstrated to induce the expression of glycogen synthesis genes in hepatocytes (Petrie et al., 
2013). Therefore, MondoA-Mlx promote the metabolism excess intracellular Glc by directing it 
through different pathways, while limiting excessive Glc uptake. 
Table 1: Examples of direct MondoA-Mlx activated targets: 
Gene Functions: Cell type/tissue Reference 
ARRDC4 Glc uptake inhibition Melanoma cells Parmenter et al., 2014 
HKII Glc phosporylation Myoblast Sans et al., 2006 
LDH-Aa Lactate metabolism Myoblast Sans et al., 2006 
PFKFB3b Carbohydrate metabolism Myoblast Sans et al., 2006 
PTGc Glycogen metabolism Hepatocyte Petrie et al., 2013 
TXNIP Glc uptake inhibition; 
redox regulation 
HA1ER Stoltzman et al., 2008 
a LDH-A – lactate dehydrogenase A; b PFKFB3 – phosphofructo-2-kinase/fructose-2,6-
bisphosphatase; c PTG- protein targeting to glycogen 
1.6.2.4.3. ChREBP-Mlx regulate the expression of lipogenic genes 
Since its discovery, ChREBP has rapidly been unveiled as a master regulator of several key enzymes 
in glycolysis and lipogenesis (for direct targets, see Table 2). Curiously, ChREBP and the Sterol 
regulatory element binding protein 1 c (SREBP1c) have been found to act synergistically on several 
of their lipogenic and glycolytic targets (Dentin et al., 2004). Moreover, experimental evidence exists 
to indicate direct regulation of the SREBP1 gene by ChREBP-Mlx in HepG2 cells (Jeong et al., 2011). 
Based on microarray data, approximately 75% of Glc-elicited transcriptional response in hepatocytes 
appears to be mediated by Mlx (Ma et al., 2006). As the more prevalent Mondo protein in the liver, 
majority of Mlx-dependent changes seen in hepatocytes are therefore expected to be facilitated by 
ChREBP. It is noteworthy that pre-diabetic and type 2 diabetic patients display lower expression of 
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ChREBP and its targets in WAT, while elevated expression is apparent in liver samples (Kursawe et 
al., 2013). Moreover, the same study found a clear positive correlation between insulin sensitivity and 
ChREBP expression in WAT. Thus, the role of ChREBP-Mlx in regulating carbohydrate metabolism 
and conversion to TAG is critical for metabolic homeostasis maintenance. Yet the significance of 
tissue-specific expression differences and concurrent physiological effects continue to be discussed 
(Richards et al., 2017).  
Table 2: Examples of direct ChREBP-Mlx activated targets: 
a 6PDG - 6-phosphogluconate dehydrogenase; b DEC1 – deleted in esophageal cancer 1: c GPDH – 
glycerol-3-phosphate dehydrogenase; d Klf10 – Krüppel-like factor 10; e ME2 – Mitochondrial malic 
enzyme 2 
Given the key role that ChREBP plays in lipogenesis and carbohydrate metabolism, ChREBP knock-
out mice displayed slightly elevated plasma Glc levels and about 50% reduction in circulating FFA 
levels. Moreover, with a standard diet, the adipose tissue deposits of these animals were significantly 
smaller, likely due to reduced fatty acid synthesis (Iizuka et al., 2004). Notably, such mice displayed 
normal embryonic development and adult life span under standard conditions. However, attempts to 
feed ChREBP -/- mutant mice diets high in simple sugars resulted in dramatic and rapid deterioration 
of the animals. In particular, a 70% sucrose diet caused the death of more than half of the tested mutant 
mice within a week, whereas, a diet high in Fru resulted in a terminal decline after just few days 
(Iizuka et al., 2004). For ChREBP knock-out mice, a diet high in sugar resulted in a further decline 
of circulating FFA levels, accompanied by progressive hypothermia (Iizuka et al., 2004). Apparently, 
these animals suffered from metabolic problems that are aggravated by dietary sugars. However, 
despite the characterization of these initial findings, the underlying reasons for the dietary sugar 
intolerance have remained unexplored. 
1.6.2.4.4. Common modifiers of the circadian clock and ChREBP-Mlx 
Overexpression experiments of a dominant negative variant of Mlx in hepatocytes have indicated a 
transcriptional regulation of G6PD, most likely by ChREBP-Mlx (Ma et al., 2006). G6PD is the rate-
limiting enzyme in the PPP and produces NADPH by metabolizing G6P. Moreover, another enzyme 
from the pathway 6-phosphogluconate dehydrogenase (6PGD), that likewise produces NADPH, has 
been identified as a direct ChREBP target in macrophages (Sarrazy et al., 2015). Through NADPH 
metabolism, PPP has recently been demonstrated to regulate circadian gene oscillations and 
Gene Functions: Cell type/tissue Reference 
6PGDa PPP Macrophage Sarrazy et al., 2015 
ACC De novo lipogenesis Liver Ishii et al., 2004 
DEC1b Transcriptional repressor Hepatocyte Iizuka and Horikawa, 2008 
FAS De novo lipogenesis Liver, macrophage Ishii et al., 2004; Sarrazy et al., 
2015 
G6Pase GlcNG, glycogenolysis Liver Arden et al., 2012 
GLUT4 Glc transport HEK293 Ma et al., 2006 
GPDHc Glycerol metabolism HEK293 Ma et al., 2006 
KLF10d Transcriptional repressor Liver Iizuka et al., 2011 
ME2e Mitochondrial malate and 
NADPH metabolism 
Macrophage Sarrazy et al., 2015 
PK Glycolysis HEK293 Ma et al., 2006 
TXNIP Glc uptake inhibition; 
redox regulation 
INS1; β-cells Cha-Molstad et al., 2009 
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behavioral rhythmicity, underlining the potential contribution of ChREBP-Mlx to the circadian output 
(Rey et al., 2016). 
KLF10 (Krüppel-like factor 10) and DEC1 (Deleted in esophageal cancer 1) are two transcriptional 
repressors that have been proposed to modulate the lipogenic gene expression response elicited by 
ChREBP-Mlx. Both Klf10 and DEC1 promoters possess a Glc-responsive ChoRE and have been 
confirmed as direct targets for ChREBP-Mlx in primary hepatocytes (Iizuka and Horikawa, 2008; 
Iizuka et al., 2011). However, the physiological relevance of this Glc-dependent regulation has not 
been studied in vivo. Curiously, DEC1 has been demonstrated to compete with ChREBP-Mlx 
complexes in binding the E-box elements present in ChoREs, thereby inhibiting Glc-responsive gene 
expression, including its own (Iizuka and Horikawa, 2008). More strikingly, as they are both proposed 
to be direct targets of the molecular clock, KLF10 and DEC1 have been linked to the control and 
output of the circadian rhythm (Guillaumond et al., 2010; Honma et al., 2002). DEC1 also directly 
inhibits the expression of clock genes by competing with CLOCK-BMAL1 for E-box elements in 
CCG promoters. (Honma et al., 2002), whereas KLF10 has been found to be important for circadian 
gene expression oscillations, especially in terms of lipogenic and carbohydrate metabolism 
(Guillaumond et al., 2010). DEC1 gene appears to be more highly expressed in diabetic and insulin-
resistant humans (Coletta et al., 2008), while loss of klf10 in male mice leads to PEPCK-dependent 
hyperglycemia (Guillaumond et al., 2010). Evidently, both of these TFs contribute to metabolic 
homeostasis. It is noteworthy that the core molecular clock CLOCK-BMAL1, DEC1, and 
MondoA/ChREBP-Mlx complexes recognize similar elements in promoters – E-boxes and ChoREs 
composed of two E-boxes. At least for the ChoRE in the promoter of DEC1, the same E-box has been 
demonstrated to be bound by both the molecular clock and ChREBP-Mlx (Honma et al., 2002; Iizuka 
and Horikawa, 2008). Therefore, it is possible that CLOCK-BMAL1 and MondoA/ChREBP-Mlx 
share other direct targets, and potentially either compete or synergize to regulate their expression. 
Thus, by regulating the expression of circadian modulators such as DEC1 and klf10, ChREBP-Mlx 
may coordinate the synchronization of nutrient signals to circadian rhythm. Elaborate feedback loops 
between ChREBP-Mlx, their targets, and the circadian clock seem to exist to help maintain metabolic 
homeostasis throughout daily fluctuating nutrient levels. 
1.6.2.4.5. ChREBP-Mlx as regulators of antioxidant profile 
Similarly to MondoA, ChREBP has also been found to regulate TXNIP expression (Cha-Molstad et 
al., 2009). TXNIP protein is known to interact and, as a result, inhibit the antioxidant properties of 
thioredoxin. As such, TXNIP has been suggested to possess an inhibitory role in cancer progression 
(Zhou and Chng, 2013). However, reporter comparisons in HeLa cells have revealed a 7-fold more 
potent response on TXNIP promoter by MondoA, when compared to ChREBP (Yu et al., 2009). 
Nevertheless, the dominance of TXNIP regulation may be tissue dependent. As TXNIP is an 
antioxidant modifier, changes in ChREBP-Mlx are expected to affect the oxidative stress response. 
G6PD and 6PGD, two enzymes from the PPP reducing NADPH, have been demonstrated to lie 
transcriptionally downstream of ChREBP-Mlx in primary hepatocytes and macrophages, respectively 
(Ma et al., 2006; Sarrazy et al., 2015). PPP is the main source of cytoplasmic NADPH, while fatty 
acid synthesis is the main consumer (Fan et al., 2014). Thus, it is fully expected that the upregulation 
of lipogenic genes by ChREBP-Mlx in response to high sugars would be accompanied by increased 
NADPH production to sustain lipogenesis. In addition, the mitochondrial Malic enzyme 2 (ME2), 
that also reduces NADPH, has similarly been identified as a direct ChREBP target in macrophages 
(Sarrazy et al., 2015). NADPH has a central function in cellular antioxidant maintenance, as it is a 
substrate for glutathione reduction. Consequently, knocking down ChREBP in macrophages resulted 
in a 30-fold decrease in the NADPH/NADP+ ratio, subsequently reduced lipid synthesis, and reduced 
glutathione levels (Sarrazy et al., 2015). Moreover, ChREBP-deficient macrophages displayed higher 
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susceptibility to ROS inducers, resulting in an increased inflammatory response, caspase activation, 
and subsequent necrosis. The ChREBP-deficiency dependent inflammation and cell death could be, 
however, rescued by the addition of exogenous reduced glutathione (Sarrazy et al., 2015). Therefore, 
at least in macrophages, ChREBP-Mlx dependent gene regulation is crucial to ensure sufficient 
antioxidant production for ROS tolerance. Yet, macrophages as cells are specialized for ROS 
generation to help battle infection. Moreover, ROS levels in phagocytes, including macrophages, are 
substantial (about 2μM for O2- and between 1-4 μM for H202; (Slauch, 2011)). Thus, whether 
ChREBP-Mlx regulate NADPH reduction in metabolic tissues, and if such a modulation has 
consequences on systemic oxidative stress response, has not yet been investigated. 
1.7 AMPK-related kinases 
Another well-characterized cellular energy sensor is AMPK, which is nearly universal among 
eukaryotes (Hardie et al., 2012). AMPK belongs to the AMPK-related kinase family, regulated by the 
master-kinase Liver kinase B1 (LKB1) (reviewed in (Bright et al., 2009). Its principal function lies in 
monitoring cellular AMP/ATP ratio. Fasting, hypoxia, and exercising diminish the available ATP in 
the cell, while the AMP levels undergo a consequential surge. In order to help sustain the metabolic 
needs of the altered energetic conditions, AMPK activation is triggered (Hardie, 2004). As a result, 
anabolic energy-consuming reactions, such as protein and glycogen synthesis, gluconeogenesis, and 
lipogenesis are inhibited, while catabolic processes including fatty acid oxidation, autophagy, Glc 
uptake, and glycolysis are promoted (Hardie et al., 2012). Moreover, by promoting the salvage 
pathway of NAD+ synthesis, AMPK also affects the redox state of the cell (Cantó et al., 2009; Han 
et al., 2016). In addition to its critical role at the energy checkpoint, AMPK has been proposed to 
elicit anti-proliferative effects on cancer cells, most likely due to shutting down the anabolic metabolic 
reactions required for cell-division (Alessi et al., 2006). This has prompted researchers to investigate 
the plausibility of using the antidiabetic drugs functioning through AMPK activation, such as 
metformin, as treatment options for cancer, and CVD (Pryor and Cabreiro, 2015). 
1.7.1 Salt-inducible kinases 
In mammals, the AMPK-related kinase family is composed of 14 kinases. In addition to AMPK 
kinases, however, the regulation of metabolic effectors is also facilitated by another group of kinases 
from the same family – the Salt-inducible kinases (SIKs) (reviewed by Shackelford and Shaw, 2009). 
The kinases were so named because the first orthologue, SIK1, was initially cloned and identified 
from rat adrenal glands fed a diet high in salt (Wang et al., 1999). Subsequent similarity searches in 
mammalian genomes helped to identify SIK2 and SIK3 (Katoh et al., 2004a). Overall, the kinases 
demonstrate evolutionary conservation in animals, as the Drosophila, Xenopus, and zebrafish 
genomes all encode for two SIK proteins, while C. elegans has a single SIK gene (Funato et al., 2016; 
Okamoto et al., 2004). Moreover, due to a high level of conservation, the SIK3 kinase domain 
sequence displays extensive identity (71%) and similarity (86%) between humans and flies (Choi et 
al., 2015). In mammals, SIKs show distinct gene expression patterns: SIK1 is detectable in adrenal 
glands, testes and skeletal muscle; SIK2 is highest in adipose tissue and brain, and functions also in 
the liver; while SIK3 is expressed ubiquitously at a more moderate rate (Dentin et al., 2007; Horike 
et al., 2003; Katoh et al., 2004a; Okamoto et al., 2004). In flies, SIK2 functions as an orthologue of 
both SIK1 and SIK2, and is mostly expressed in the brain (Choi et al., 2011; Okamoto et al., 2004). 
The fly SIK3 kinase has been found to be highly expressed in the fat body (Choi et al., 2015; Wang 
et al., 2011). 
Contrary to AMPK, SIKs are single subunit enzymes devoid of glycogen and AMP sensitivity 
domains (Hardie, 2004) (see Figure 8). LKB1-dependent phosphorylation of a conserved and critical 
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Thr residue in the kinase domain T-loop has been proposed to be essential for nearly all AMPK-
related kinases, including thee SIKs (Lizcano et al., 2004) (see Figure 8). However, at least for SIK2, 
other regulatory mechanisms independent of LKB1 have also been suggested (Altarejos and 
Montminy, 2011; Miranda et al., 2016). The C-terminal domain of the SIK kinases harbors a PKA 
phosphorylation site that is well conserved, and acts as a NLS (Katoh et al., 2004b) (Figure 8). 
Despite this, under in vitro conditions the PKA-dependent phosphorylation seem to have no effect the 
activity of SIK kinases per se (Berdeaux et al., 2007; Katoh et al., 2006). Rather, the main PKA-
dependent regulatory mechanism on the SIK kinases is likely mediated by phosphorylation-dependent 
subcellular sequestration, and subsequent separation from substrates. In vitro, mammalian SIK2 has 
been found to be activated by insulin through AKT-dependent phosphorylation (Dentin et al., 2007). 
This mechanism seems to be conserved in Drosophila, as both fly SIK kinases can be activated 
through the same mechanism (Figure 8), while the fly glucagon counterpart adipokinetic hormone 
inhibits SIK3 activity through LKB1 (Choi et al., 2015; Wang et al., 2008, 2011). Thus, SIK kinases 
appear to be regulated by several important metabolic kinases. 
 
Figure 8: A simplified schematic comparison of AMPK and SIK domain structures. AMPK is 
composed of three subunits: the kinase domain-containing catalytic subunit AMPKα, and the 
regulatory subunits AMPKβ and AMPKγ. The regions marked as “complex” on the figure dictate the 
trimer formation. The regulatory subunits contain domains for glycogen and AMP/ADP/ATP binding. 
An NLS present in certain AMPKα isoforms has not been marked to the figure. Similarly to AMPK, 
the SIK kinase domain harbors an activating LKB1-phosphorylation site. The SIK C-terminal domain 
contains an NLS, and the inhibitory PKA-phosphorylation site. Additionally, the activating AKT-
phosphorylation site that has yet to be experimentally demonstrated for SIK1 is marked on the figure. 
Proteins not drawn to scale. Based on Berdeaux, 2011 and Hardie et al., 2012. 
1.7.1.1 SIKs as regulators of growth and metabolism 
Studies with different model organisms have helped to uncover the physiological function of SIKs. 
To date, a number of SIK phosphorylation target proteins have been identified (see Table 3), many 
of which either control or participate in metabolic processes. For example, cAMP-regulated 
transcriptional co-activators (CRTCs) are well-characterized targets for all SIKs (Patel et al., 2014) 
(Table 3). CRTC together with its partner cAMP-responsive element-binding protein (CREB) 
promote the expression of genes involved in GlcNG. As a result, SIKs have been established as crucial 
inhibitors of GlcNG in the liver, where they seem to function redundantly (Patel et al., 2014). 
Consequently, due to uninhibited CRTC, SIK2 null flies have been found to be starvation resistant, 
and possess larger glycogen and lipid deposits (Choi et al., 2011). However, pan-SIK inhibitor 
treatments induced Glc production even in CRTC-deficient primary hepatocytes (Patel et al., 2014). 
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Therefore, the SIKs most likely contribute to carbohydrate homeostasis also through additional 
means. 
Another group of well characterized SIK targets is the class IIa histone deacetylases (HDACs) (Table 
3). All three SIKs have been demonstrated to phosphorylate this subset of HDACs, resulting in their 
cytoplasmic sequestration, and consequent inactivation (Berdeaux et al., 2007; Walkinshaw et al., 
2013). The class IIa HDACs have been linked to Glc homeostasis through activation of Forkhead box 
O (FoxO), and regulation of GlcNG gene expression (Mihaylova et al., 2011; Wang et al., 2011). 
Notably, inhibition of class II HDACs may help alleviate hyperglycemia, as witnessed by experiments 
conducted in type 2 diabetic mouse models (Mihaylova et al., 2011). Curiously, the lack of SIK-
dependent HDAC4 inhibition in SIK3 knock-out mice has been demonstrated to result in dwarfism 
due to impaired chondrocyte growth control (Sasagawa et al., 2012). Moreover, the same mice exhibit 
diminished lipid stores, hypoglycemia, and impaired cholesterol metabolism (Uebi et al., 2012), but 
whether these metabolic phenotypes are the result of unregulated HDACs, has not yet been studied. 
As SIK3 null mutant flies have been published to be early larval (Wang et al., 2011) or pupal lethal 
(Choi et al., 2015), a hypomorphic allele has been used for experimental purposes in Drosophila 
(Wang et al., 2011). Such flies have reduced TAG levels, are developmentally delayed, and exhibit 
increased sensitivity to starvation and the oxidative stress-inducer paraquat (Wang et al., 2011). The 
absence of HDAC4 inhibition through SIK3-dependent cytoplasmic sequestration in response to 
feeding in these animals leads to deacetylation, and hence, nuclear accumulation and activation of 
FoxO. As a result, the expression of a FoxO target lipase brummer is enhanced in SIK3 hypomorphs, 
and is consequently proposed to explain the reduced TAG stores, and starvation sensitivity observed 
in these flies (Wang et al., 2011). Importantly, many of the aforementioned SIK3 hypomorphic fly 
phenotypes, and also SIK3 null lethality, can be rescued by restoring the kinase expression in the fat 
body (Wang et al., 2011), indicating that SIK3 function is essential in this metabolic organ. The loss 
of the single SIK orthologue in C. elegans similarly results in a developmental delay. Despite 
increased food foraging, SIK mutant worms are smaller in size, indicating a potential role in growth 
control for this kinase. Moreover, these animals are long-lived – a phenotype that can be normalized 
by simultaneous loss of the C. elegans FoxO orthologue (Lanjuin and Sengupta, 2002). Thus, FoxO 
may also lie downstream of SIK in C. elegans, but whether this putative regulation occurs through 
HDACs, has not been investigated. 
Direct evidence of SIK-dependent growth control comes from studies conducted in Drosophila. 
Namely, both SIK2 and SIK3 have been demonstrated to promote growth by inhibiting the Hippo 
pathway. This regulation occurs through SIK2- and SIK3-dependent phosphorylation of the Hippo 
pathway scaffolding protein Salvador (Sav), resulting in its inability to bridge the association between 
Hippo and Warts – the key kinases of the pathway (Wehr et al., 2013). Consequently, the Warts-
dependent inhibitory phosphorylation of Yorkie is reduced (Wehr et al., 2013), resulting in its 
increased nuclear localization. As Yorkie promotes cell proliferation and survival, over-expressing 
active SIK2 in the fly wing results in significantly increased wing area (Wehr et al., 2013). Moreover, 
through the involvement of Hippo pathway regulation, both SIK2 and SIK3 have been demonstrated 
to contribute to insulin-dependent dietary sugar enhancement of tumor growth in an activated Ras/Src 
fly model (Hirabayashi and Cagan, 2015). Interestingly, in mammals, SIK2 and SIK3 have recently 
been implicated in promoting tumor progression in ovarian and prostate cancer (Bon et al., 2015; 
Charoenfuprasert et al., 2011; Miranda et al., 2016). As high levels of SIK2 are often detected in 
adipocyte-rich ovarian cancer metastases, the kinase is suggested to play a role in tumor 
metastasizing. Mechanistically, by inhibiting lipogenesis at the level of ACC and activating the pro-
survival, pro-proliferation kinase Phosphoinositide 3-kinase (PI3K) by phosphorylating its regulatory 
subunit, SIK2 has been proposed to link metabolic control and growth in cancer (Miranda et al., 2016). 
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Table 3: Examples of known SIK-phosphorylation targets: 
a IRS-1 – Insulin receptor substrate 1 
Based on a number of targets, the consensus site for SIK-dependent serine and threonine 
phosphorylation motifs has been well characterized (Horike et al., 2003; Screaton et al., 2004; Wang 
et al., 2011; Wehr et al., 2013): ΦX[HKR]XX[S/T]XXXΦ, where Φ stands for a hydrophobic residue, 
and X for any amino acid. However, whether all the SIK targets contain the aforementioned consensus 
motif, is currently uncertain. The phosphorylation event in question often forms a 14-3-3 chaperone 
binding site, resulting in the cytoplasmic sequestration of some substrates, such as CRTC and certain 
HDACs (Berdeaux et al., 2007; Screaton et al., 2004). However, for SREBP1-c, IRS-1, and p300, the 
inhibitory effect elicited by SIK phosphorylation occurs independently of 14-3-3 (Berdeaux, 2011; 
Bricambert et al., 2010; Yoon et al., 2009). For SREBP1-c, the SIK1 dependent phosphorylation of 
serine residues in the bHLH/LZ domain appears to abolish the DNA-binding ability of the TF, without 
any effect on its subcellular localization or stability (Yoon et al., 2009). 
Evidently, the AMPK and SIK kinases share several common target proteins, including CTRCs, class 
II HDACs, SREBP1c, ACC, and IRS-1 (Horike et al., 2003; Jakobsen et al., 2001; Koo et al., 2005; 
Li et al., 2011; McGee et al., 2008; Miranda et al., 2016; Park et al., 2002; Walkinshaw et al., 2013; 
Yoon et al., 2009). Similar to AMPK, this may indicate a central role for SIK kinases in metabolic 
homeostasis. Moreover, accumulating experimental evidence points to the possibility that the SIK 
kinases function to link metabolic regulation to growth control. Such characteristics delineate SIKs 
as potential targets for metabolic syndrome and cancer treatment. However, much of their function 
and downstream effector regulation remains uninvestigated, and further experiments are required for 
more complete understanding, before therapeutic targeting of SIKs can be considered.  
SIK 
# 
Target 
protein 
Target protein 
function: 
Regulatory 
consequence 
Cell type/tissue Reference 
2 ACC Lipogenesis Inhibition Different ovarian 
cancer cell lines 
Miranda et al., 
2016 
1, 2, 
3 
Class IIa 
HDACs 
Deacetylation Inhibition HEK293, MEF, 
Hela, A549 (SIK2 
& 3); myocytes 
(SIK1) 
Berdeaux et al., 
2007; 
Walkinshaw et al., 
2013 
1, 2, 
3 
CRTC; 
CRTC2 
Transcriptional 
co-activator 
Inhibition Adrenal cells 
(SIK1); adipocytes 
(SIK2); hepatocytes 
(SIK3) 
Itoh et al., 2015; 
Lee et al., 2015; 
Park et al., 2014 
2 IRS-1a Insulin signal 
transmission 
Inhibition COS-7 Horike et al., 2003 
2 p85α Regulatory 
subunit of PI3K 
Activation Different ovarian 
cancer cell lines 
Miranda et al., 
2016 
2, 3 Sav Hippo-pathway 
regulation 
Inhibition S2R+; Drosophila 
wing 
Wehr et al., 2013 
1 SREBP1c TF Inhibition Liver Yoon et al., 2009 
23 
 
2. Aims of the study 
MondoA and ChREBP, along with their transcriptional partner Mlx, have been demonstrated to 
mediate the majority of Glc-responsive gene expression. While efforts have been made to investigate 
the biological significance of MondoA/ChREBP-Mlx-dependent transcriptional control, most 
physiological consequences of their target gene expression regulation remain unknown. 
The Drosophila genome encodes for single proteins for Mondo and Mlx (McFerrin and Atchley, 
2011). More importantly, the key Glc-sensitive element GSM of Drosophila Mondo protein can 
readily substitute for its mammalian counterpart in ChREBP, without decreasing sugar-
responsiveness (Ma et al., 2006). This demonstrates high level of functional conservation. The aim of 
this work was to investigate the physiological role of the Mondo-Mlx complex, by using Drosophila 
as a model organism. Another major goal was to dissect the relevance of Mondo-Mlx dependent gene 
expression in response to sugar diet.  
In sum, the specific goals for this thesis were: 
1) To broaden the understanding of Mondo-Mlx function in vivo  
2) To identify direct Mondo-Mlx targets, and investigate the physiological role of their 
transcriptional regulation downstream of these TFs 
3) To characterize novel signaling pathways involved in sugar sensing 
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3. Materials and methods 
Detailed descriptions of the materials and methods used throughout this study can be found in the 
respective articles and their corresponding supplementary information. A summarizing table outlining 
the applied methods is listed below (Table 4). The fly lines that were used, and their origin, can be 
found in Table 5. The plasmids and primary antibodies implemented throughout the thesis are shown 
in Table 6 and Table 7, respectively. 
 
  Table 4: Summary table of the methods used 
Method Publication 
ChIP II, III 
Circulating Glc and trehalose measurement I, II, III 
Circulating glycerol measurement II 
Co-immunoprecipitation and HA-pulldown I, III 
Colorimetric feeding assay II 
Fly husbandry I, II, III 
Glycogen measurement I 
Hemolymph pH III 
In vitro kinase assay III 
Luciferase reporter assay II 
Molecular cloning II, III 
Pupal volume measurement II 
RNA extraction and qPCR I, II, III 
S2 cell culture and transfection I, III 
TAG measurement II, III 
Western Blotting and Phos-Tag I, III 
Drosophila fly husbandry 
Flies were kept at 25 °C in 12 h light: 12 h dark cycles. For defined nutrient experiments, 1st instar 
larvae were collected from apple juice plates onto food at a fixed density. The low sugar diet (LSD) 
contained 20% (w/v) dry baker's yeast, 0.5% (w/v) agarose, 2.5% (v/v) Nipagin (methylparaben), and 
0.7 % propionic acid in PBS. For sugar feeding, the LSD was supplemented with 5-20% sucrose. A 
diet containing 20% sucrose in this setting was referred to as high sugar diet (HSD) For starvation, 
2nd instar larvae were transferred to 0.5% agarose in PBS media for 16 h, followed by 4 h of refeeding 
with 0.5% agarose and 10% Glc in PBS media. For sugar only feeding, 1st instar larvae were collected 
to 0.5% agarose in PBS supplemented with 20% sucrose. For acute sugar feeding experiments, late 
2nd instar or early third instar larvae were transferred onto high sugar (10 or 20%) diet for 16 h before 
samples were harvested. The used fly and RNAi lines are listed in Table 5. 
  Table 5: Used fly lines 
Fly line Stock nr. and source or reference Publication 
Cabut RNAi 4427R-1, NIGa I, II 
Canton-S 64349, BDSCb II 
cbtE1 Muñoz-Descalzo et al., 2005 II 
Control for mlx1 Generated by V. Hietakangas for this study I, II, III 
Control for PEPCKΔ84 This study II 
Df(2R)ED3636 150416, BDSC II 
Mlx RNAi v110630 (KK), VDRCc I 
mlx1 Generated by V. Hietakangas for this study I, II, III 
Mondo RNAi v109821 (KK), VDRC I, III 
P{EPgy2}EY1004 19965, BDSC II 
25 
 
Table 5, continued   
Fly line Stock nr. and source or reference Publication 
pepck1 (CG17725) RNAi v50253 (GD), VDRC II 
pepck2 (CG10924) RNAi 36915, BDSC II 
PEPCKΔ84 Generated by M. Poukkula II 
PHGPx RNAi 33939, BDSC III 
r4-GAL4 (Lee and Park, 2004) I, II 
SIK3 RNAi 28366, BDSC III 
SIK3Δ72 (Wang et al., 2011) III 
Tim-GAL4 (Zhao et al., 2003) II 
TrxR-1 110648 (KK), VDRC III 
Tub-GAL4 (Lee and Luo, 1999) I, II, III 
Tub-GAL80ts (McGuire et al., 2003) I, II 
UAS?cbt?Flag (Muñoz-Descalzo et al., 2005) II 
UAS?Dicer 2 (Dietzl et al., 2007) II 
UAS-mlx-Flag Generated by V. Hietakangas for this study I, II 
UAS-strep-Zw-6xP-mut-PB-3HA  Generated for this study III 
UAS-strep-Zw-PB-3HA Generated for this study III 
Ubi-GAL4 32551, BDSC III 
y1 w1118 6598, BDSC III 
Zw RNAi v108898 (KK), VDRC III 
a BSC – Bloomington Drosophila Stock Center 
b NIG - National Institute of Genetics, Japan 
c VDRC - Vienna Drosophila Resource Center 
HepG2 and S2 cell culture and transfection 
HepG2 (human hepatocellular carcinoma) cells were grown in complete MEM media (5.5 mM Glc), 
supplemented with or without high Glc (25 mM, final concentration). Transfections were carried out 
with Lipofectamine 2000 based on manufacturer’s guidelines. 
Drosophila S2 (circulatory macrophage-like) cells were grown at 25°C in standard or Glc-free 
Shield’s and Sang M3 media (Sigma and US Biological), supplemented with 2% of fetal bovine serum 
(Gibco), 1× insect medium supplement (Sigma) and penicillin/streptomycin (Gibco). The 
transfections with plasmids listed in Table 6 were performed using Effectene (Qiagen), according to 
manufacturer's protocol. Expression from pMT and pUAST vectors was induced with 1.2 μM CuSO4 
24 h post-transfection, cells were harvested 48 h post-induction. 
  Table 6: Plasmids used in this thesis 
Plasmid Reference or source Publication 
pUAST-Mlx-Flag Generated by V. Hietakangas for this 
study 
I 
pMT-strep-Mondo-3xV5 Generated by J Mattila I 
pMT-GAL4 (Klueg et al., 2002) I 
pRL-SV40 Promega, E2231 II 
pGL3 basic Promega, E1751 II 
pGL3 Cabut ChoRE 1 & 2 wt Generated for this study II 
pGL3 Cabut ChoRE 1 mut, ChoRE2 wt Generated for this study II 
pGL3 Cabut ChoRE 1 wt, ChoRE2 mut Generated for this study II 
pGL3 Cabut ChoRE 1 & 2 mut Generated for this study II 
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Table 6, continued
Plasmid Reference or source Publication
pMT-strep-G6PD-PA-3HA Generated for this study III
pMT-strep-G6PD-PB-3HA Generated for this study III
pMT-strep-SIK3-PA-3V5 Generated for this study III
pMT-strep-SIK3-PB-3V5 Generated for this study III
pUAS-strep-G6PD-PB-3HA Generated for this study III
pUAS-strep-G6PD-6xP-mut-PB-3HA Generated for this study III
  Table 7: Used primary antibodies
Primary antibody Source or reference Publication
Guinea pig anti-Mlx Generated by E. Havula for this study I
Mouse anti-V5 Life Technologies, R96025 I, III
Mouse anti-HA Life Technologies, 326700 III
Rabbit anti-Kinesin Cytoskeleton, AKIN01 I, III
Statistical analysis
All experiments were performed in minimum three biological replicates. The data are represented as
the average ± standard error of the mean (SEM) (I) or the average ± standard deviation (II, III). All
quantitative data were analyzed by Student's t-test (two-tailed, unequal variance), where p < 0.05 was
considered significant. The significance of pupariation and survival curves for publication III was
evaluated by using the Log-Rank test (JMP Pro 12 software).
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4. Summary of results and discussion 
4.1 The Drosophila Mondo and Mlx physically interact and show functional conservation 
In mammals, two Mondo proteins exist that after dimerizing with Mlx, promote the expression of 
Glc-responsive genes. Due to common ancestry, MondoA and ChREBP share a visibly similar 
structure, and are also proposed to be regulated by the same metabolites (Havula and Hietakangas, 
2012; McFerrin and Atchley, 2011; Petrie et al., 2013). In addition, both TFs recognize similar 
elements in their target gene promoters. Despite their different predominant tissue expression pattern, 
both ChREBP and MondoA have been described to function in the liver and skeletal muscle (Ahn et 
al., 2016; Hanke et al., 2011; Ma et al., 2006; Petrie et al., 2013). Moreover, at least one common 
direct target gene is shared between the paralogous TFs, while similar pathways have been 
demonstrated to be regulated by MondoA and ChREBP. Therefore, these TFs may be partially 
redundant in mammals. 
In contrast, the Drosophila genome harbors a single copy of both Mondo and Mlx: Mondo (CG18362, 
also known as Mio), and Mlx (CG3350; official name bigmax). This eliminates the possibility of 
redundancy. The level of functional conservation and sugar-responsiveness between the GSM of the 
fly and mammalian Mondo proteins has been experimentally demonstrated (Ma et al., 2006). 
Moreover, when we compared the Mlx protein sequences in flies and humans, we discovered a high 
level of identity (32.2%) and similarity (45.3%) (Figure 9). 
In mammals, the paralogous TFs 
MondoA and ChREBP interact with Mlx 
to form heteromers (Ma et al., 2007; 
Peterson et al., 2010) – a pre-requisite for 
nuclear entry and transcriptional 
regulation. However, whether the fly 
counterparts also directly interact, has not 
yet been shown. Thus, by carrying out a 
co-immunoprecipitation experiment with 
over-expression constructs in Drosophila 
S2 cells, we confirmed the interaction of 
the fly Mondo and Mlx proteins (I, Fig. 
2A). 
A loss of one of the protein partners 
would be expected to abolish the function 
of the Mondo-Mlx complex. Thus, to 
investigate the physiological role of these 
TFs, we generated an mlx1 mutant fly through imprecise P-element excision and, in parallel, a precise 
P-element excision line to be used as a genetic control. Upon an Mlx-specific Western blot, three 
protein bands were visible in control larval sample that were absent in the mlx1 homogenate. However, 
in an S2-cell lysate sample, two prominent protein bands were seen (I, Fig. S2). In both cases, despite 
different intensity ratios, the upper-most band appeared to be the most prevalent one. However, Mlx 
is reported to possess only a single splice-variant in the fly. Moreover, proteolytic processing cannot 
explain the detection of several bands, as N- and C-terminal tag-mediated affinity-purification 
resulted in comparable band intensities (data not shown). In addition, by using alkaline phosphatase 
treatment, we ruled out phosphorylation. In addition, treatment with an OGT inhibitor failed to change 
the Mlx protein band pattern (data not shown). Therefore, the nature of the multi-band Mlx protein 
Figure 9: Pairwise alignment of human (γ-isoform; 
upper row) and Drosophila Mlx. We analyzed the 
protein sequences with Emboss Needle. Identical 
residues are marked in dark blue, and similar residues 
with lighter blue color. 
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remains unresolved. Sumoylation, ubiquitinylation, or other post-translational modifications could be 
plausible candidates. 
4.2 Mondo-Mlx are required for dietary sugar tolerance 
While analyzing the mlx1 mutants on a standard lab diet, we noticed a moderate developmental delay, 
culminating in pupal lethality during the pharate stage. In mammals, MondoA/ChREBP-Mlx have 
been implicated in carbohydrate utilization through sugar-responsive gene expression control. 
Moreover, mice lacking ChREBP have been demonstrated to deteriorate after being fed a diet high in 
simple sugars. By adding increasing concentrations of sucrose to the fly food, and monitoring the 
developmental kinetics of mlx1 mutants or Mondo RNAi animals, we demonstrated that the functional 
Mondo-Mlx complex is required for dietary sugar tolerance in Drosophila (I, Fig. 1D, E). 
By qPCR, we determined the tissue-specific expression of mlx and mondo. In accordance with the 
mammalian data, the fly orthologues displayed highest expression in peripheral metabolic tissues, 
especially in the fat body, gut, and Malpighian tubules (I, Fig. 5A). Moreover, expressing mlx in the 
fat bodies of mlx1 animals rescued pupal lethality on LSD and intolerance to HSD (I, Fig. 5B). Thus, 
Mondo-Mlx function is essential in the fat body for dietary sugar tolerance. 
4.3 Loss of Mondo-Mlx function results in imbalanced carbohydrate profile 
To gain further insight into this striking phenotype, we analyzed the metabolic profile of mlx1 mutants. 
We uncovered elevated levels of sorbitol (III, SFig 2A), and circulating levels of Glc and trehalose 
(I, Fig. 4A, B). These aberrations are a clear indication of impaired carbohydrate metabolism. 
Notably, however, a sugar-dependent increase was apparent only in sorbitol and Glc levels, while 
trehalose was also elevated in response to a LSD. Compared to circulating Glc levels, trehalose levels 
have been proposed to be less responsive to environmental cues (Graham and Pick, 2017; Ugrankar 
et al., 2015). This may explain the lack of further increase in trehalose levels following sugar feeding. 
Importantly, loss of either Mondo or Mlx also lead to high body glycogen levels (I, Fig. 4C, F). This 
result is in agreement with observations from ChREBP knock-out mice, where loss of this TF 
similarly resulted in elevated glycogen levels (Iizuka et al., 2004). Therefore, Glc uptake to cells likely 
remains functional in these animals, but further Glc metabolism through glycolysis or lipogenesis 
may be hampered. Curiously, knock-down of lipogenic genes ACC and FAS has been demonstrated 
to result in increased fat body glycogen levels (Garrido et al., 2015). As both of these genes are 
expressed at a lower rate in the mlx1 mutants (I, Fig. 6D), it is plausible that the observed elevated 
glycogen levels are a direct consequence of impaired lipogenesis. Lipogenesis and glycogen synthesis 
predominantly take place in the fat body, where Glc from hemolymph is directed. Upon the 
impairment of one of these Glc-storage pathways, it is conceivable that the other one is upregulated 
for compensation purposes. Accordingly, the high glycogen phenotype was rescued in glycogen 
synthase and ACC or FAS double knock-down animals (Garrido et al., 2015). However, whether 
impaired conversion of Glc to glycogen results in increased lipogenesis has not yet been addressed in 
flies.  
4.4 Mondo-Mlx directly regulate the expression of TF Cabut 
As Mondo-Mlx act as TFs, the phenotypes observed upon their loss are likely to be the consequence 
of deregulated gene expression. Thus, in order to discover candidate genes downstream of Mondo-
Mlx contributing to sugar intolerance, we performed a microarray analysis from mlx1 mutants fed a 
moderate (5%) sugar diet. Because the sugar tolerance depends on Mondo-Mlx function in fat bodies, 
we chose this tissue to investigate their regulatory output. Nearly 200 genes were differentially 
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expressed (> 2-fold change; adjusted p-value <0.05) in mlx1 mutant fat bodies. Based on the KEGG 
and gene-set enrichment analysis, many of the affected genes are categorized as functioning in fatty 
acid and nitrogen metabolism (I, Figure 6B, C). 
Interestingly, one of the most strongly downregulated genes in mlx1 mutants was Cabut. Moreover, 
our results demonstrated that Cabut expression is induced by sugar feeding and this induction depends 
on Mondo-Mlx (II, Fig 1A). Cabut belongs to the family of Krüppel-like (Klf) transcription factors, 
with Klf10 and Klf11 being its closest mammalian homologs. These TFs have been implicated in a 
broad range of cellular processes, including proliferation, differentiation, and apoptosis (Spittau and 
Krieglstein, 2012). In addition, Klf11 has been demonstrated to protect from fatty liver disease (Zhang 
et al., 2013), while genetic variants of klf10 have been linked to susceptibility to type 2 diabetes 
(Gutierrez-Aguilar et al., 2007). 
It is noteworthy that the Klf10 promoter possesses a sugar-responsive ChoRE that has been 
demonstrated to be directly bound by ChREBP-Mlx (Iizuka et al., 2011). However, the metabolic 
consequence of this supposed regulation has not been studied. Thus, to investigate whether Cabut is 
a direct target of Mondo-Mlx, we first examined the promoter region of the gene. We found two 
putative ChoRE sequences from the Cabut gene region: one upstream of the transcription start site, 
the second in an intron (II, Fig. 1B). Comparisons among Drosophilids revealed that these elements 
are conserved, and may hence be functionally relevant. To test this, we constructed luciferase-reporter 
vectors containing combinations of wild type and mutated ChoREs. Next, we measured the activity 
of these constructs in Drosophila S2 cells. However, we failed to detect a Glc-dependent response in 
these cells. Given that S2 cells have been proposed display characteristics of a macrophage-like 
lineage (Luce-Fedrow et al., 2008), it is possible that this cellular context lacks certain co-regulators 
necessary for Mondo-Mlx-dependent gene expression regulation. Thus, the human hepatocarcinoma 
cell line HepG2, which has been established as a relevant experimental setting for ChREBP (Jeong et 
al., 2011), we analyzed the Glc-responsiveness of the candidate Cabut ChoRE elements in this setting. 
The Cabut promoter reporter containing two ChoREs, or only ChoRE2, demonstrated increased 
activity in response to high Glc in the media, while loss of ChoRE1 reduced this significantly (II, Fig. 
1E). This suggests that ChoRE1 may be relevant for sugar-responsiveness. To confirm direct 
regulation, we performed an Mlx-dependent chromatin immunoprecipitation (ChIP) assay from 
Drosophila S2 cells grown with or without Glc for 6h. This revealed that both ChoRE elements were 
significantly bound by Mondo-Mlx, and the enrichment was further increased by the addition of Glc 
(II, Fig. 1D). While looking into the physiological relevance of this regulation, we discovered that 
similar to mlx1, ubiquitous knock-down of Cabut in flies resulted in dietary sugar intolerance (I, Fig 
7A). In sum, our data demonstrates that Mondo-Mlx dependent regulation of Cabut is direct, sugar-
dependent, and required for dietary sugar tolerance. 
4.5 Cabut modulates molecular clock output 
Klf10, Klf11, and Cabut have mostly been described as transcriptional repressors (Belacortu et al., 
2012). However, both Klf10 and Klf11 have been demonstrated to regulate gene expression though 
interacting with transcriptional co-repressors and co-activators (Spittau and Krieglstein, 2012). For 
example, a recent report demonstrated, that by interacting on the chromatin with the Hippo-pathway 
effector Yorkie, Cabut functions as a transcriptional activator (Ruiz-Romero et al., 2015). Thus, the 
nature of the transcriptional regulation by Klf10, Klf11, and most likely for Cabut may depend on 
cellular context and the activity of other signaling pathways. 
As Cabut is a direct sugar-inducible target of Mondo-Mlx, it likely controls a second tier of sugar-
regulated gene expression. Moreover, since the loss of Cabut results in dietary sugar intolerance, it is 
likely that its function as a transcriptional regulator is needed for carbohydrate homeostasis. To study 
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the Cabut-dependent transcriptome, we collaborated with S. Kadener’s lab in Israel. Microarray and 
RNA-sequencing experiments were performed from flies, where Cabut expression had been 
manipulated. Cabut is a vital developmental gene, and is crucial for such processes as dorsal closure 
(Belacortu et al., 2011). Moreover, due to its auto-regulatory function (Belacortu et al., 2012), forced 
Cabut expression may lead to unexpected outcomes. Therefore, it was not surprising that ubiquitous 
and even fat body-specific manipulations in Cabut expression resulted in embryonic or early lethality 
(data not shown). However, as Cabut expression has been suggested to be regulated by the core 
circadian clock (Abruzzi et al., 2011), a Tim-GAL4 driver was tested. Overexpression or knock-down 
of Cabut using this driver resulted in viable flies. Since the nature of the circadian rhythm is much 
less understood in larvae than adults, the latter developmental stage was chosen for our experiment 
setup. Tim is known to be heavily expressed in the brain. Moreover, in adults, a subset of the fat body 
surrounds the brain (Hwangbo et al., 2004). Consequently, the transcriptomic experiments were 
performed from fly heads, where Cabut was either knocked down or overexpressed by Tim-GAL4. 
For this, the animals were first starved and fed either increasing concentrations of a sucrose or exposed 
to sucrose diet for different periods of time (0-18 h). 
The data from the microarray experiment demonstrated that many Cabut-affected genes fall into such 
categories as metabolism, immune response, and CCGs (II, Fig. 2A). Hyperglycemia is known to 
cause an increase in ROS levels (Giacco and Brownlee, 2010). ROS, on the other hand, are both 
mediators and inducers of defense responses such as inflammation and immune signaling (Mittal et 
al., 2014). Thereby, Cabut may function to modulate the inflammatory response elicited by dietary 
sugar-generated ROS. In addition, the evidence of both CCGs and metabolic genes downstream of 
Cabut suggests that this TF may coordinate nutritional and time-of-day cues. In support of this 
hypothesis, lost behavioral rhythmicity in flies was detected upon Cabut over-expression (II, Fig. 
6A). Such a phenotype is a clear indicator of aberrant circadian rhythm in flies. Experimental evidence 
from ChIP tiling array assays indicates that similar to its mammalian counterpart klf10, cabut 
promoter is directly bound by the components of the molecular clock (Abruzzi et al., 2011). Thus, 
Cabut may be regulated by the circadian clock and dietary sugars to coordinate downstream circadian 
gene expression control with nutritional cues. To this end, an RNA-sequencing experiment from fly 
heads harvested during different times throughout the day was performed, and the effect of Cabut 
manipulation on circadian gene oscillations was analyzed. The cycling of core circadian genes (Tim, 
Clk, vri) was unaffected by Cabut (II, Fig 6B, D). Strikingly, however, a number of genes ceased to 
oscillate in both Cabut RNAi and over-expression samples. More peculiarly, a subset of genes not 
cycling in control background, could be seen oscillating upon Cabut manipulation (II, Fig 6B, D). 
When the affected genes were analyzed according to their gene ontology classification, the Cabut 
RNAi group was significantly enriched in metabolic processes (II, Fig 6E). In, sum, these data 
indicate that sugar-induced Cabut feeds nutritional information into circadian rhythm by executing 
oscillatory transcriptional control. 
4.6 Cabut represses metabolic genes, including both PEPCK isoforms 
The sugar-induced temporal RNA-sequencing experiment demonstrated that Cabut functions to 
repress a number of metabolic genes in response to sugar feeding (II, Fig. 2D, E). Cabut-mediated 
repression appears to be rapid, as the full effect is visible already after 6 h of sugar-feeding. The 
evidence of such targets as the lipase brummer and gluconeogenic genes (pepck, fbp) suggests that 
Cabut likely functions to inhibit energy generation from lipolysis and Glc-production from other 
metabolites, when sugars are present in the food. 
The strongest affected gene in the Cabut-dependent transcriptome experiments encodes PEPCK-C 
PEPCK (CG17725; pepck1). PEPCK-C is the rate-limiting enzyme of both GlcNG and GlyNG and 
is thus subjected to strict regulation. The main level of PEPCK-C regulatory control has been 
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suggested to occur at the level of transcription (Hanson and Reshef, 1997). Many TFs sensitive to the 
insulin-glucagon balance are potent inducers of GlcNG gene expression in response to starvation. 
These include the CREB-CRTC complex upon short term starvation (Altarejos and Montminy, 2011), 
as well as the FoxO, HNF4α, and PGC1-α mediated transcriptional regulation upon prolonged fasting 
(Puigserver et al., 2003; Rhee et al., 2003). FoxO, especially, has received attention in GlcNG gene 
expression control, as increased hepatic Glc output upon insulin insensitivity can be attenuated by 
loss of FoxO (Samuel et al., 2006). Thus, it is unsurprising that PEPCK-C has been implicated in the 
development of type 2 diabetes (Beale et al., 2007). 
Notably, in the Drosophila genome, the gene encoding the mitochondrial variant of PEPCK (PEPCK-
M encoded by pepck2; CG10924) is located immediately next to the cytoplasmic variant. Moreover, 
both isoforms appear to be regulated by Cabut, as their levels are several-fold higher in knock down 
animals (II, Fig 3, A, C, E). Through ChIP, we confirmed this regulation to be direct. pepck1 
expression was induced by fasting and rapidly inhibited by sugar re-feeding (II: Fig 3B; SFig. 6A, 
C). However, depleting Cabut by RNAi largely abolished the sugar-dependent downregulation of 
pepck1 expression (II, Fig. 3B). These results suggest that in response to dietary sugars Cabut inhibits 
the expression of pepck genes. 
In accordance with Cabut being an important effector of Mondo-Mlx, we showed that mlx1 mutants 
demonstrated similar elevated gene expression levels of both pepck isoforms (II, Fig. 3C, E). More 
importantly, by expressing Cabut in the fat bodies mlx1 mutants, we were able to alleviate the high 
expression of both pepck variants (II, Fig. 3D; SFig 6E). We conclude that fat body Mondo-Mlx 
mediated control of Cabut expression is crucial for pepck inhibition. 
4.7 Cytoplasmic PEPCK is not essential for viability, but controls glycerol levels 
To investigate the physiological function of PEPCK-C downstream of Mondo-Mlx and Cabut, an 
imprecise P-element excision mutant of pepck1 was generated (pepckΔ84). To avoid genetic 
background-dependent effects, we used the mutant line in trans with a genomic deficiency line that 
lacks both pepck gene coding regions (PEPCKΔ84/Df(2R)ED3636). Accordingly, as a control, we 
used a precise excision P-element line in trans with yw background. qPCR experiments revealed that 
the pepck1 expression in mutant/deficiency combination larvae was approximately 1000-times lower, 
when compared to controls (II, Fig. 4B), indicating that the pepckΔ84 allele is likely null or at least 
strongly hypomorphic for pepck1. Mice lacking cytoplasmic PEPCK-C have been reported to 
succumb to neonatal lethality due to extreme hypoglycemia (Hakimi et al., 2005). In contrast, we 
observed comparable pupariation and eclosion rates between the PEPCKΔ84/Df(2R)ED3636 and 
heterozygous pepck1 flies (II, Fig. 4C). Moreover, their developmental speed and pupal volume were 
unaffected (II, SFig. 7B, C). This demonstrates that pepck1 is non-essential for viability in flies. 
Notably, the expression of pepck2 was unaltered in PEPCKΔ84/Df(2R)ED3636 animals (data not 
shown). Thus, it can be speculated, that the mitochondrial variant may compensate the lack of pepck1 
to avoid lethality. 
PEPCK-C is the rate limiting enzyme in GlcNG, with trehalose as the final product in insects. 
Therefore, we assayed both circulating Glc and trehalose levels from PEPCKΔ84/Df(2R)ED3636 
larvae. Despite being well fed, these animals displayed moderately reduced levels of both metabolites 
(II, Fig.4 D, E). In addition to limiting GlcNG, PEPCK-C is also crucial for the functioning of GlyNG 
– a stunted version of GlcNG, where the final product is G3P. To this end, we measured circulating 
glycerol levels in larvae lacking pepck1. Notably, PEPCKΔ84/Df(2R)ED3636 larvae had nearly 60% 
less glycerol in their hemolymph, despite being well fed (II, Fig.4F). Similar results were obtained 
with pepck1 and pepck2 RNAi constructs (II, SFig. 7D), indicating that both PEPCK isoforms affect 
systemic glycerol levels. As G3P is a substrate for FFA esterification in the formation of TAG, we 
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measured whole body TAGs from animals lacking pepck1. In accordance with the circulating glycerol 
data, the TAG stores in PEPCKΔ84/Df(2R)ED3636 adult flies were decreased by 57%, but this 
difference was only apparent in males (II, Fig. 4G). Thus, PEPCK function may have contrasting 
metabolic consequences in males and females. In agreement with this, through Klf10, PEPCK-
dependent effects have been reported to result in sex-dependent alterations in metabolite levels in 
mice (Guillaumond et al., 2010). We conclude that loss of cytoplasmic PEPCK leads to reduced 
glycerol output, and consequently, lower TAG levels. 
4.8 Mondo-Mlx and Cabut orchestrate glycerol homeostasis through pepck regulation 
Due to very low cabut expression (II; Fig. 1A), mlx1 mutant larvae display 5-7-times higher pepck1 
expression (II, Fig. 3C,D). As pepck directly reflects on circulating glycerol (II, Fig. 4B, F), we 
assayed the levels of this metabolite in mlx1 mutant larvae. Importantly, we observed a more than 5-
fold increase in the level of circulating glycerol (II; Fig. 5C, D) that correlated well with pepck1 
expression in mlx1 mutants. To directly test whether excessive pepck1 expression resulted in 
hemolymph glycerol accumulation in these animals, we combined the mlx1 mutants with 
PEPCKΔ84/Df(2R)ED3636. Indeed, this combination resulted in a full rescue of high circulating 
glycerol levels, while elevated trehalose levels underwent a moderate decrease (II, Fig. 5D, E). We 
conclude that the elevated circulating glycerol, and to a certain extent, high trehalose levels in mlx1 
mutants are the consequence of high pepck expression. 
Moreover, we noticed that the pupal lethality observed in mlx1 mutants on standard lab diet was 
overcome by simultaneous loss of pepck1 in these animals (II, Fig. 5F). However, the mlx1 dietary 
sugar intolerant phenotype was unaffected in this combination (data not shown). It is likely, that 
control of GlyNG at the level of pepck expression by Mondo-Mlx and Cabut functions to direct the 
flow of carbon backbones obtained from Glc. Namely, upon high Glc conditions, efficient Glc-
clearance is achieved by promoting Glc-utilizing pathways, while competing processes, such as 
GlcNG and GlyNG, are inhibited. However, upon loss of functional Mondo-Mlx, glycolysis and 
lipogenesis are impaired. Moreover, due to low cabut expression, excess glycerol and trehalose are 
produced through PEPCK-dependent GlcNG and GlyNG. Combined, these aberrations tip the 
metabolic imbalance, leading to pupal lethality in mlx1 mutants. In accordance with high the pepck 
expression in these animals, the PEP to OAA ratio was significantly increased in both mlx1 mutant 
and Cabut RNAi larvae (II, Fig. 5A, B). However, Cabut RNAi animals displayed no significant 
differences in circulating glycerol levels (data not shown). This may be explained by functional 
lipogenic gene regulation in these animals (II, SFig. 8D). Therefore, upon loss of Cabut, excess 
carbon backbones from Glc, and glycerol produced through GlyNG are likely converted into TAGs. 
In agreement with this, female knockout mice of the mammalian orthologue Klf10 display increased 
plasma TAG content (Guillaumond et al., 2010). In sum, we conclude that Mondo-Mlx dependent 
regulation of Cabut is essential for proper pepck expression, and consequently, for glycerol and 
trehalose homeostasis.  
4.9 Mondo-Mlx regulate SIK3 expression to promote sugar tolerance 
While looking for other Mondo-Mlx downstream effectors in addition to Cabut, we identified SIK3 
as their direct target. The SIK3 promoter contains a putative ChoRE that shows conservation among 
Drosophilae (III, Fig. 2D). However, compared to the Cabut ChoRE elements, the SIK3 ChoRE 
sequence appears to be more degenerate, and as a result, displayed lower, yet still significant levels 
of enrichment in an Mlx-dependent ChIP (compare II, Fig. 1D and III, Fig. 2E). In agreement with 
this, mlx1 mutants clearly displayed lower levels of SIK3, both in terms of developmental stage and 
tissue-specific expression (III, Fig. 2A, B). Moreover, SIK3 expression was elevated in response to 
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sugar feeding in a Mondo-Mlx-dependent manner (III, Fig 2C). However, cabut expression appears 
to depend more on Mondo-Mlx than SIK3, as observed by lower basal-level expression in mlx1 
mutants (II, Fig 1A). This may indicate that other transcriptional regulators than Mondo-Mlx are 
potentially involved in controlling SIK3 expression. We conclude that SIK3 is transcriptionally 
downstream of Mondo-Mlx. 
To study the physiological role of SIK3 downstream of Mondo-Mlx, we took use of published mutant 
flies. Two mutant SIK3 alleles have been generated through imprecise P-element excision by the 
Montminy lab: a null variant SIK3Δ72 and a hypomorph SIK3Δ48 (Wang et al., 2011). Complete loss 
of SIK3 in SIK3Δ72 mutants has been reported to result in early larval lethality, while the hypomorphs 
are viable, yet display reduced starvation sensitivity due to lower TAG stores (Wang et al., 2011). 
However, when we tested the null mutation on a LSD, we noticed that close to half of the animals 
managed to develop to the pupal stage. Although, adding 15 % sucrose to the diet, abolished 
pupariation (III, Fig. 1A). Therefore, SIK3 is required for dietary sugar tolerance. This phenotype 
suggests that the “standard” lab diet used by Wang et al. (2011) likely had relatively high sugar 
concentration, and thus led to early larval lethality in SIK3Δ72.  
4.10 Loss of SIK3 results in high sorbitol and trehalose levels 
To obtain further insight to the sugar-intolerant phenotype observed upon loss of SIK3, we analyzed 
the levels of several relevant metabolites. Due to the lack of a precise P-element excision line, we 
used a yw line, which corresponds to the original genetic background of SIK3Δ72 mutant animals, as 
a control genotype. In contrast to mlx1, but similarly to loss of Cabut (I, Fig. 4A, 7E), SIK3Δ72 mutants 
displayed comparable circulating Glc levels with controls (III, Fig. 1E). This suggests that dietary 
sugar intolerance cannot solely be explained by hyperglycemia, and is likely a complex phenotype. 
Similar to mlx1 mutants, however, the SIK3Δ72 mutants showed elevated sorbitol and circulating 
trehalose levels (III, Fig. 1F, H). These results indicate, that even though circulating Glc levels are 
maintained in a normal range upon loss of SIK3, it may come at a cost of increased polyol pathway 
activity, resulting in sorbitol build-up. We demonstrated that the high circulating trehalose in mlx1, 
however, is at least partly the result of high pepck expression in these mutants (II, Fig. 3C; 5E). 
Importantly, the SIK kinases are well-established repressors of the co-activator CRTC (Choi et al., 
2011; Itoh et al., 2015; Lee et al., 2015). CRTC together with CREB function to promote the 
expression of GlcNG genes, including pepck. In addition, over-expression of HDAC4 in flies has 
been demonstated to result in elevated pepck expression (Wang et al., 2011). Importantly, due to the 
lack of inhibitory phosphorylation, 
HDAC4 has been found to be over-
active in SIK3 mutant flies (Wang et al., 
2011). In agreement with this, we 
observed high pepck1 expression in 
SIK3Δ72 mutants (Figure 10). Thus, 
similar to mlx1, overactive GlcNG may 
contribute to increased circulating 
trehalose levels in SIK3Δ72 mutants.  
We also confirmed the previously published observations that loss of SIK3 leads to reduced TAG 
stores (Wang et al., 2011; III, SFig. 1B). Moreover, we determined that lower TAG levels were not 
a consequence of reduced lipogenic gene expression profile in these animals (Figure 11). On the 
contrary, lipogenic gene expression seems to be enhanced in SIK3 mutants in a manner that is 
independent of Mondo-Mlx (data not shown). In mammals, SIK1 is known to inhibit the function the 
lipogenic gene regulator SREBP1-c (Yoon et al., 2009). Flies, however, lack this SIK variant, and 
Figure 10: The expression 
of pepck1 is elevated in 
SIK3Δ72 mutants. qPCR 
experiment from 1st instar 
larvae grown on LSD. Gene 
expression was normalized 
to Actin. 
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instead, SIK2 has been proposed to 
cover the function of both SIK1 and 
SIK2. Yet, SIK2 displays a 
predominant expression in the brain 
(Choi et al., 2011; Wang et al., 2008). 
Thus it is possible that in more 
metabolic tissues, such as the fat body, 
where SIK3 is the predominant variant 
in the fly, SREBP function may also be 
modulated by SIK3. 
 
Recently, a high carbohydrate diet was demonstrated to cause high carbohydrate-dependent lethality 
in Drosophila mutants of the TGFβ ligand Dawdle. Curiously, this phenotype was accompanied by 
hemolymph acidification (Ghosh and O’Connor, 2014). Intriguingly, we found the same phenotype 
manifested by both mlx1 and SIK3Δ72 mutant larvae (III, Fig. 1I; SFig. 2B), indicating that loss of 
SIK3 downstream of Mondo-Mlx may lead to lowering of hemolymph pH levels. Next, we 
investigated whether elevated lactate levels could help explain the acidification observed in SIK3Δ72 
mutants. We discovered, however, that the low hemolymph pH occurs independently of dietary sugar 
feeding, while lactate elevation is only apparent on a HSD (III, Fig. 1G, I). Ghosh and O’Connor 
reported that the systemic acidosis due to low hemolymph pH is the consequence of accumulated 
TCA intermediates in Dawdle mutants. Whether such a metabolic imbalance also occurs in SIK3Δ72 
and mlx1 mutants, has yet to be determined. 
4.11 SIK3 directly interacts with Glucose-6-phosphate dehydrogenase to induce its 
phosphorylation 
Our group recently demonstrated that Mondo-Mlx regulate the PPP by increasing the expression of 
several genes in the pathway in a sugar-inducible manner (Mattila et al., 2015). Moreover, Mondo-
Mlx directly bind to the promoter of the zwischenferment (zw) gene that encodes the rate-limiting 
enzyme of the pathway: Glucose-6-phosphate dehydrogenase (G6PD) (Mattila et al., 2015). 
Consequently, the mlx1 mutants display strongly reduced zw expression. Moreover, knock-down of 
G6PD in the fly renders the animals sugar intolerant and results in decreased TAG levels, likely due 
to a decreased level of NADP+ reduction (Mattila et al., 2015). As HSD causes similar aberrations in 
SIK3Δ72 mutants, we looked for evidence of potential cross-talk between these two Mondo-Mlx 
targets.  
To this end, we performed a co-immunoprecipitation between different SIK3 and G6PD isoforms 
over-expressed in S2 cells. The results demonstrate that SIK3 and G6PD directly interact in an 
isoform-independent manner (III, Fig. 3A). In addition, by performing a Phos-Tag Western blot 
(Kinoshita et al., 2006), we noted the presence of several phosphorylated bands of G6PD upon SIK3 
co-over-expression (Figure 12, upper panels). Through in vitro kinase assay, we further confirmed 
Figure 11: The 
expression of 
lipogenic genes is 
increased upon loss 
of SIK3. qPCR data 
from 1st instar larval 
samples grown on 
LSD. Gene expression 
was normalized to 
Actin. 
Figure 12: Co-expression of G6PD and SIK3 in S2 
cells results in the appearance of phosphorylated 
bands. Phosphorylation is isoform (A and B, for both 
SIK3 and G6PD) independent. Tagged constructs 
were expressed in Drosophila S2 cells. Samples were 
lysed and resolved on a Phos-Tag Western blot. 
Kinesin was used as a loading control. 
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the SIK3-dependent phosphorylation of G6PD (III, Fig. 3C). Although a SIK3-dependent 
phosphorylation consensus sequence has been characterized based on several targets (Wang et al., 
2011; Wehr et al., 2013), we did not find any visible matches in the G6PD protein. This may indicate 
either that other, as yet uncharacterized, SIK3 consensus sequences exist, or the witnessed SIK3-
dependent G6DP phosphorylation occurs indirectly through an unknown SIK3-activated kinase. 
Thus, to identify the SIK3-dependent phosphorylation sites in G6PD, a mass-spectrometric analysis 
from purified G6PD protein co-expressed with or without SIK3 was performed. This resulted in the 
identification of 8 phosphorylation sites, of which 6 were detected only upon SIK3 co-expression (III, 
Fig., 3D; SFig. 3B). Notably, as SIK3 is a Ser/Thr kinase, the presence of Tyr384 among the SIK3-
dependent phosphorylation sites points to the presence of secondary phosphorylation event.  
4.12 SIK3 promotes G6PD activation in a sugar-dependent manner 
To dissect the physiological relevance of SIK3-dependent G6PD phosphorylation, we created 
transgenic flies with: a wild type G6PD, and a 6-fold mutant G6PD, where the SIK3-dependent 
phosphorylation sites were mutated into either Ala (Ser and Thr), or Phe (Tyr). Both protein variants 
were strep- and hemagglutinin (HA)-tagged. By using a ubiquitous GAL4 driver, we expressed the 
G6PD transgenes in larvae grown on LSD, and exposed to 16 h of HSD. Next, the larvae were lysed 
and subjected to affinity purification by using Strep-Tactin microplate wells. This was followed by 
direct measurement of the purified G6PD enzymatic activity. To normalize the obtained values to the 
amount of input G6PD protein, we performed an HA-dependent Western blot from the total lysate, 
followed by digital signal intensity quantification with the Odyssey infrared imaging system. When 
we compared the normalized enzymatic activity of the two affinity purified proteins, we observed that 
the activity of the wild type G6PD was increased by HSD, while no change occurred in the 6-fold 
mutant (III, Fig. 3E). This result suggested that SIK3-dependent G6PD phosphorylation functions to 
increase the enzyme activity in response to sugar feeding. 
To further confirm this, we measured G6PD enzyme activity from SIK3Δ72 larvae exposed to HSD 
for 16h. In agreement with the previous experiment, the enzyme activity in control animals was 
increased after sugar feeding. However, this response was absent in stage-matched SIK3Δ72 mutants 
(III, Fig. 3F). Furthermore, zw expression upon loss of SIK3 was unchanged (III, Fig 3H). Thus, we 
conclude that the SIK3-dependent activation of G6PD in response to dietary sugar clearly occurs at a 
post-translational level, and depends on some or all of the identified phosphorylation sites. 
4.13 Mondo-Mlx and SIK3 synergize to regulate G6PD and sugar tolerance 
Both SIK3 and zw lie transcriptionally downstream of Mondo-Mlx, and their expression is promoted 
in response to sugar feeding (Mattila et al., 2015). Loss of the sugar-induced gene expression 
regulation would be expected to reflect also in G6PD enzyme activity. In agreement with this, G6PD 
RNAi reduced G6PD enzyme activity (III, SFig. 3C). To this end, we sought out to measure G6PD 
activity in mlx1 mutants. Similar to SIK3Δ72, we observed the lack of sugar-induced upregulation of 
G6PD activity in mlx1 mutants (III, Fig. 3G). Thus, by increasing zw expression and promoting the 
transcription of its upstream activator, Mondo-Mlx appear to promote G6PD activity on two levels. 
In terms of physiological consequence, such a bifunctional control may allow fine-tuning the G6PD 
enzymatic activity over broader ranges of dietary sugar intake. Therefore, a loss of both activating 
regulators would be expected to exacerbate the dietary sugar intolerance in these animals. To test this, 
we performed a double knock-down experiment by targeting both Mondo and SIK3, and feeding these 
animals a moderate (5 %) sugar diet. Single RNAi against either targets did not impair pupariation, 
while simultaneous knock-down of Mondo and SIK3 significantly slowed down development and 
abolished pupariation in the presence of 5 % sugar (III, Fig 3I). In order to find further support for 
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the synergistic effect on sugar tolerance by SIK3 and Mondo-Mlx, we combined the SIK3Δ72 and 
mlx1 mutants. The resulting animals appeared to do unwell even on LSD (data not shown), as none of 
them developed past the 2nd instar stage. To escape the developmental problem while investigating 
dietary sugar intolerance, we reared the double mutant larvae on a diet containing 20 % sucrose as the 
sole nutritional source. Our results demonstrated that knock down of either SIK3 or Mondo-Mlx 
decreases larval survival in these conditions (I, Fig. 1C; III, Fig. 1C). A loss of both SIK3 and Mondo-
Mlx, however, further sensitized the animals to dietary sucrose (III, Fig. 3J). Combined, our results 
demonstrate the synergistic control of dietary sugar tolerance by Mondo-Mlx and SIK3. 
4.14 SIK3-dependent G6PD activation is crucial for diet-dependent redox balance maintenance 
The PPP and G6PD are key mediators of reducing cytoplasmic NADP+ to NADPH. By being a 
substrate for reducing glutathione disulfide into glutathione, NADPH is necessary for the maintenance 
of proper cellular antioxidant profile. The cellular pool of reduced glutathione is vital for fighting 
oxidative damage (Pompella et al., 2003). As the G6PD activity appears to be decreased upon HSD 
in SIK3Δ72 and mlx1, we measured the balance of NADPH to NADP+ in these animals. In accordance 
with our previous data, the NADPH/NADP+ ratio in control animals underwent an increase in 
response to HSD, while this response was absent in SIK3Δ72 and mlx1 mutants (III, Fig 4A; SFig. 
4A). Because NADPH is essential for reducing glutathione disulfide, we also measured the reduced 
to oxidized ratio of glutathione in SIK3Δ72 mutants. As a direct reflection of the NADPH/NADP+ 
ratio, loss of SIK3 led to relatively lower levels of reduced glutathione (III, Fig 4C). 
Hyperglycemia is a known inducer of oxidative stress (Giacco and Brownlee, 2010). Remarkably, 
experiments using SIK3 hypomorphs have demonstrated a slightly increased susceptibility to 
oxidative stress-inducer paraquat in adult flies (Wang et al., 2011). Thus, we hypothesized that a 
failure to upregulate G6PD activity in response to HSD, and consequently, the inability to maintain a 
sufficient reduced glutathione may render the SIK3Δ72 mutants more susceptible to oxidative stress. 
Thus, as a readout of oxidative damage, we measured the levels of lipid peroxides in SIK3Δ72 larvae. 
LSD had no effect on lipid peroxidation in control or mutant animals, while HSD significantly 
increased the level of lipid peroxides in SIK3Δ72 larvae (III, Fig. 4F). Thereby, to test whether an 
impaired antioxidant profile and subsequently increased susceptibility to oxidative stress could 
contribute to sugar intolerance, we knocked down an enzyme involved in glutathione metabolism – 
Thioredoxin reductase 1 (TrxR-1). This enzyme is responsible for reducing thioredoxin in a NADPH-
dependent manner (III, Fig 4B). In Drosophila, reduced thioredoxin is used to reduce glutathione 
(Kanzok et al., 2001). In support of the concept that glutathione reduction contributes to dietary sugar 
tolerance, the TrxR-1 RNAi had a lower pupariation rate on HSD, when compared to LSD (III, Fig. 
4E). 
The described results so far support the notion that HSD induces an increased requirement of 
antioxidants, and a failure to comply leads to dietary sugar intolerance. Thereby, the supplementation 
of exogenous antioxidants through feeding may relieve the level of oxidative stress, and consequent 
sugar intolerance. To test this, we compared the pupariation kinetics of SIK3Δ72 mutant animals 
grown on LSD or moderate (5 %) sugar diet, with or without the addition of reduced glutathione. The 
supplementation of glutathione had no effect on control animals, nor on SIK3Δ72 mutants reared on 
LSD. However, on a moderate sugar diet, the addition of glutathione significantly increased the 
number of pupariated animals (III, Fig. 4 D). This result further supports the notion that the dietary 
sugar intolerance witnessed in SIK3Δ72 mutants is at least partly the consequence of impaired redox 
balance. 
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5. Final remarks and future perspectives 
The work carried out in this thesis takes use of conserved pathways in Drosophila, to aid in the 
characterization of the physiological role of Mondo-Mlx TFs upon sugar feeding. Our results 
demonstrate that Mondo-Mlx activity is essential for dietary sugar tolerance. Furthermore, we provide 
additional evidence, that by directing the flow of carbon backbones, Mondo-Mlx promote Glc-
clearance. Furthermore, our data implies that metabolic gene regulation and circadian rhythm control 
converge at the level of Mondo-Mlx target Cabut. We uncover a double regulatory function of 
Mondo-Mlx, whereby antioxidant profile in the form of glutathione is upregulated in the anticipation 
of higher oxidative stress due to increased sugar consumption. 
Specifically, we characterize the phenotype of flies lacking mlx. As a striking observation, we note 
the developmental impairment of these animals in high dietary sugar conditions. Despite increased 
channeling of Glc into glycogen, they are hyperglycemic and also display high circulating trehalose 
levels. By performing a microarray and ChIP experiments, we identify TF Cabut as a direct, sugar-
inducible target, and secondary effector of Mondo-Mlx. Similar to its upstream regulators, we show 
that Cabut is required for dietary sugar tolerance. Moreover, we characterize Cabut as sugar-
dependent transcriptional inhibitor of many metabolic genes, including both pepck variants. We 
dissect the importance of pepck gene expression regulation, and subsequent glycerol homeostasis, 
mediated by Mondo-Mlx through Cabut. The inability to inhibit pepck results in the accumulation of 
circulating glycerol that contributes to pupal lethality upon loss of Mondo-Mlx activity. We propose, 
that in order to help utilize the Glc consumed with food, this regulatory mechanism functions to limit 
GlyNG and GlcNG following feeding. Notably, we report that in Drosophila, the cytoplasmic PEPCK 
is not essential for viability, but whether this is due to functional redundancy of the mitochondrial 
PEPCK, has to be addressed by future studies. In addition, we demonstrate that Cabut interconnects 
nutrient sensing with circadian rhythm output. Altered Cabut activity results in aberrant locomotor 
rhythmicity. This reveals that Cabut integrates nutrient sensing and circadian rhythm output. 
However, whether Mondo-Mlx contribute to the cycling of circadian genes independently of Cabut, 
has yet to be determined. 
We describe the importance of increasing reductive power in response to high sugar diet. Specifically, 
we demonstrate that G6PD activity directly correlates with organismal antioxidant profile in the form 
of reduced glutathione. Furthermore, we provide mechanistic evidence, that in addition to 
transcriptional upregulation of G6PD, Mondo-Mlx also promote the activity of this enzyme through 
their direct target gene encoding kinase SIK3. With the use of mass-spectrometric analysis, we 
identify a number of amino acid residues in G6PD that are phosphorylated in a SIK3 dependent- 
manner. In addition, we provide evidence, that these phosphorylation sites are important for 
augmenting the G6PD enzyme activity post-translationally following high sugar consumption. 
However, whether G6PD is directly phosphorylated by SIK3, or if secondary kinases downstream of 
SIK3 are involved, will be the topic of future studies. As a result, loss of either SIK3 or Mondo-Mlx 
function abolishes the sugar-dependent increase in G6PD activity and subsequent elevation in the 
NADPH/NADP+ ratio. As a direct repercussion, SIK3 mutant animals have lower levels of reduced 
glutathione, and consequently, display hallmarks of oxidative damage. These defects in SIK3 mutants 
directly contribute to dietary sugar tolerance, as observed by a moderate rescue of this phenotype 
following reduced glutathione supplementation with the diet. Interestingly, both SIK3 function and 
reduced NADPH levels have recently been implicated in circadian control (Funato et al., 2016; Rey 
et al., 2016). Therefore, the regulation of G6PD and SIK3 expression by Mondo-Mlx suggests that, 
in addition to Cabut-mediated cycling of circadian genes, these Mondo-Mlx may have a more 
extensive involvement in circadian rhythm. 
Thus, the results of this thesis describe the relevance of directing the flow of carbon backbones, 
maintaining a redox balance, and coordinating circadian rhythm function in response to sugar sensing 
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(see summarizing Figure 13 on the next page). In sum, our results emphasize that dietary sugar 
tolerance is genetically multi-factorial, as loss of Mondo-Mlx and several of their targets (Cabut, 
SIK3, G6PD and others) results in impaired survival upon high sugar diet. Thus, we characterize 
Mondo-Mlx as master regulators of pathways required for healthful Glc-utilization. As the 
components of the identified networks are all well conserved between Drosophila and mammals, the 
results of this thesis help understand the steps required for healthful sugar intake also in the context 
of human health. Moreover, such knowledge can be valuable in designing new treatment approaches 
or drugs to help fight metabolic disorders. 
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Figure 13: Summary of the uncovered Mondo-Mlx-regulated pathways in this thesis. In response 
to increased Glc levels, Mondo-Mlx complex promotes the expression of target genes G6PD (Mattila 
et al., 2015), SIK3 and Cabut by binding to ChoRE elements present in their promoters. Cabut 
functions as a secondary effector downstream of Mondo-Mlx, and inhibits the expression of many 
metabolic genes, including both pepck variants and CCGs. This regulation is required to maintain 
glycerol homeostasis and proper circadian rhythm in response to sugar feeding. Secondly, we 
demonstrate that the Mondo-Mlx transcriptional targets SIK3 and G6PD interact at the protein level, 
resulting in the phosphorylation and subsequent activation of G6PD. As a result, the cellular 
reductive power in the form of increased NADPH/NADP+ ratio is elevated, leading to increased levels 
of reduced glutathione. Combined, the regulation of G6PD through SIK3 and Mondo-Mlx is 
necessary for redox balance maintenance and dietary sugar tolerance. 
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